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Abstract
Community pharmacy practice in Ontario is undergoing a paradigm shift, moving from a
product-centered to a patient-centered orientation. As a result of increased demands on Ontario’s
healthcare system, the provincial government enacted legislation that expanded the scope of
practice for pharmacists, authorizing them to deliver clinical services in a pharmacy setting. The
provincial government also introduced a regulated pharmacy support staff role, the Pharmacy
Technician (PT) to assist pharmacists in managing the resulting higher demands on them. This
Organizational Improvement Plan (OIP) seeks to address performance concerns in an
organization that operates two community pharmacies that arose as a result of these legislative
changes. The OIP advocates for a comprehensive approach to organizational change that focuses
on both external and internal organizational factors that contributed to the problem of practice.
The OIP champions a leadership approach that emphasizes both structural and relational
elements of leadership. Through a patient education initiative, the OIP attempts to counter
misperceptions that patients may have regarding the roles that different pharmacy team members
play. The OIP also proposes redesigning the pharmacy workflow process in order to better
integrate PTs, enable pharmacists to improve the delivery of clinical services, and achieve
efficiencies within the pharmacy. These changes are introduced in the OIP through a detailed
leadership-driven implementation plan which is complemented by a change process monitoring
and evaluation strategy and a change communication plan. While this OIP was tailored
specifically to the needs of one organization, this problem of practice is not unique to it. As such,
the analysis that was performed, the proposed leadership approach, and the change plan that was
devised can provide important insights to other community pharmacies within Ontario, across
Canada, as well as in other countries where similar legislation has been introduced.
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Executive Summary
Community pharmacy practice in Ontario has undergone major changes over the last two
decades (Gregory & Austin, 2007). For the longest time, a pharmacist’s role was largely limited
to dispensing drugs prescribed by physicians to customers (Remington, 2006), which generated a
business mindset in pharmacists and contributed to a public perception of pharmacists as profitdriven purveyors of products as opposed to healthcare professionals (Perepelkin & Dobson,
2009). Increasing demands on the healthcare system, however, led the provincial government to
revisit the role that pharmacists play in the delivery of services and the management of disease in
an effort to alleviate some of the pressure on the system. As a result, in 2009, Bill 179 came into
effect and expanded the scope of practice for pharmacists, allowing them to deliver clinical
services in community pharmacy settings, such as renewing prescriptions, administering certain
drugs by injection, and managing chronic diseases such as hypertension (Ontario College of
Pharmacists [OCP] 2012, 2014). This legislative change precipitated several outcomes in
community pharmacies, chief of which was an increased demand and higher workloads for
pharmacists, who in addition to being responsible for the drug dispensing role, were now also
required to deliver clinical services to patients. As a result, the provincial government introduced
a new regulated pharmacy support staff role, the Pharmacy Technician (PT) in order to assist
pharmacists in managing these new demands (National Association of Pharmacy Regulatory
Authorities, 2014).
This Organizational Improvement Plan (OIP) is concerned with the consequences that
this shift in community pharmacy practice from a product-centered to a patient-centered model
has had (Babb & Babb, 2003). The OIP focuses on my organization, which is a pharmacy
services company that owns and operates two franchised retail pharmacies. Since the expansion
iv

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE
of the scope of practice for pharmacists and the introduction of PTs, my organization has
experienced several concerning changes in performance such as increased dispensing error rates,
lower employee and customer satisfaction, and increased safety incidents, all of which are key
symptoms of my problem of practice. In order to better understand the context of the problem
practice, the OIP provides an extensive review of the literature and a thorough description of the
evolution of pharmacy practice in Ontario (Gregory & Austin, 2017; Lynas, 2011). In light of
this context, the OIP advocates for a leadership style that is adapted from the two prevalent
forms of exercised leadership in the organization, transactional leadership and Leader-Member
Exchange (LMX). The OIP further contends that a Structured Relational Leadership style is
required in order to address both the structural and behavioural dimensions of the problem of
practice. These dimensions were also identified by an in-depth organizational analysis using
Nadler & Tushman’s (1980) congruence model, as were other related areas of misalignment
within the organization.
To address the problem of practice, the OIP adopts a comprehensive approach to change,
and proposes a change plan based on two suggested solutions. The first is a patient education
initiative that aims to counter patient misperceptions about pharmacy support staff roles as well
as improve the delivery of clinical services. The second solution involves redesigning the
pharmacy workflow (the process by which prescriptions are filled in the pharmacy) in order to
better integrate PTs in pharmacy operations, as well as improve efficiency. To that end, the OIP
presents a detailed implementation plan for each solution, outlining the steps and the resources
that are required. The OIP employs Kotter’s (2012) eight-step organizational change framework
as the foundation for the plan’s implementation. In order to ensure that change unfolds smoothly,
and that progress and the outcomes of change are accurately captured, the OIP also provides an
v

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE
extensive monitoring and evaluation strategy. By monitoring progress and evaluating the
outcomes of change, leaders in the organization can be agile and adjust the change plan as
needed. Communication is a critical component of any organizational change initiative
(Armenakis & Harris, 2002; Kotter, 2012). Accordingly, a thorough communication strategy and
plan are put forth in the OIP to ensure that all the affected stakeholders are consulted and that
they remain well informed and engaged throughout the change process.
As with any change plan, the OIP has several limitations, the most critical being that two
solutions (change efforts) will be implemented simultaneously. This holistic approach, while
necessary, could potentially over-extend the organization’s resources and leadership, and as
such, careful monitoring and constant evaluation of progress and outcomes are essential. The
OIP’s problem of practice is complex and unraveling its roots through the organizational analysis
revealed its multi-dimensionality and that it manifests at all levels of the organization. A key
challenge for community pharmacy practice now and in the future relates to its dual existence in
the private for-profit sector and in the public healthcare domain. Despite the comprehensive
nature of the changes promoted in this OIP, it is unlikely that they will resolve this inherent
tension and the conflicting demands on my, and other organizations operating in this field. Along
the same lines, the problem of practice has significant ethical considerations which are touched
upon in the OIP, but that extend beyond my organization. It is therefore essential that the
discourse regarding the role of pharmacists as healthcare providers continues, especially in light
of the increasing demands on the entire healthcare system. The implications of simply
maintaining the status quo are far too grave for scholars and practitioners to ignore, given the
ramifications on patients’ wellbeing, health, and safety.
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Glossary of Terms

Expanded scope of practice of pharmacists: The ability for pharmacists in the province of
Ontario to provide healthcare services and perform procedures such as the delivery of drugs via
injection or inhalation, as outlined in Bill 179.
MedsCheck: A government-funded program that allows pharmacists to conduct comprehensive
reviews of patients’ medication and providing pharmaceutical treatment opinions to physicians
as required.
Pharmacy Assistant: Pharmacy support staff whose role is limited to clerical and retail duties
(e.g., prescription entry, cashing out patients). The Pharmacy Assistant role is unregulated.
Pharmacy Technician: Pharmacy support staff who are trained and certified to perform all
technical aspects of the prescription filling function including the gathering of patient
information and product preparation, distribution and inventory control. The Pharmacy
Technician role is regulated by provincial governing bodies.
Pharmacy Workflow: The standardized process for filling prescriptions and delivering services.
Structured Relational Leadership: A leadership style that combines structural elements from
Transactional Leadership such as task assignment and delegation with relational elements from
Leader-Member Exchange (LMX) such as engagement, communication and trust.
Wage-cost-per-script (WCPS): Profitability metric based on a calculation that considers the
average labour costs involved in filling a single prescription.

xi
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Chapter 1: Introduction and Problem
This Organizational Improvement Plan (OIP) examines the role of leadership and
organizational change in mitigating the impact of regulatory and legislative changes on
community pharmacy practice in Ontario, Canada. While several theoretical frameworks and
models are introduced and utilized throughout the OIP, both as framing and analytical tools that
shape the OIP’s arguments, recommendations and conclusions, at a macro-level the OIP is also
interrogated and viewed through a neoliberal lens. I chose this particular lens for two main
reasons the first of which is that neoliberalism aligns with my personal worldview and by
extension my leadership and decision-making. Second, a neoliberal understanding of the unique
organizational context within which this OIP is embedded allows for critical insights and an
appreciation of the various forces that have shaped the problem of practice as well as informed
the organizational analysis and the proposed change plan. The OIP is divided into three chapters,
the first of which provides an introduction of the organizational context and the problem of
practice. Chapter one also frames the problem of practice by examining the multilevel factors
that shape it, followed by introducing a vision for organizational change. The chapter concludes
by examining the organization’s readiness for change.
Organizational Context and History
My organization is a pharmacy services company (Organization X) that currently owns
and operates two franchised retail community pharmacies under the banner of ParentCorp in
Ontario. Founded in the mid 1900s, ParentCorp is comprised of a vast network of over 1,000
pharmacies across Canada (ParentCorp, 2018a). While pharmacies are independently owned and
operated, similar to other retail pharmacy chains in the country, ParentCorp provides store
owners with operational support through its vast logistical network and resources. Being a
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privately-owned for-profit organization providing public healthcare services and products
presents unique challenges in my operational environment, which will be explored in depth in
the organizational analysis section of the OIP in chapter two. There are also additional
challenges that have been precipitated by recent fundamental changes to the practice of
pharmacy in Ontario which I explore in the following section.
The Evolution of Pharmacy Practice – from Product to Patient-centered Care
Pharmacy practice in Ontario, across Canada (Gregory & Austin, 2017; Lynas, 2011),
and in several western countries (Koehler & Brown, 2017) is undergoing a major paradigm shift
(Nasra, 2018a). Increased demands on the healthcare system have led governing bodies to reexamine the role that community pharmacies play in the delivery of essential services to the
public, and to enact significant changes aimed at confronting the core challenges facing this
sector.
A pharmacist’s role has traditionally been associated with dispensing medications
prescribed by physicians as well as medication management (Abramowitz, 2009; Remington,
2006). These two functions are interdependent and complementary since pharmacists are the
only healthcare professionals with drug dispensing authority and knowledge of the effects of
drugs, their correct dosing, and their pharmacological appropriateness (Remington, 2006). Given
that the majority of community pharmacy practice takes place in the private retail sector, the
emphasis of pharmacy practice for many decades has traditionally been on dispensing
medications as opposed to medication management (Canadian Pharmacists Association [CPhA],
2015; Ontario College of Pharmacists [OCP], 2012). This product-centered approach engendered
a business mindset in community pharmacies which was further enhanced by the profit-driven
nature of the overall pharmaceutical industry. Over the last two decades increasing demands on
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the entire healthcare system have resulted in the resurgence of medication management and the
provision of complementary clinical services as a necessary function for pharmacists (OCP,
2012; Ontario Pharmacists Association [OPA], 2014). Legislation and a shifting business
landscape have also contributed to making these tasks, among others, central to pharmacy
practice.
The pharmacist role. Over the last decade, the Ontario Government passed regulations
and enacted changes to the laws which govern the profession of pharmacy (Lynas, 2011; OCP,
2012). In 2009, Bill 179 received royal assent to expand the scope of practice for pharmacists
(OCP, 2012; OPA, 2014). Among other things, Bill 179 authorized pharmacists to perform
several clinical functions in community pharmacies such as the renewal or adaptation of
prescriptions, the prescription of medications for smoking cessation, the administration of
vaccines and certain drugs by injection or inhalation, and the pharmaceutical management of
chronic diseases such as diabetes and hypertension (OCP, 2012; OPA, 2014).
The expanded scope of practice for pharmacists was promoted, in part, as a response to
the increased demand for healthcare services and the scarcity of resources that plagued the entire
public healthcare system (Guirguis, Johnson, & Emberley, 2014; Nasra, 2018a). It was also
viewed as one way to partially offset financial losses that pharmacies were taking on because of
additional regulations. For example, the Ontario Drug Benefit Act, introduced in 2010, reduced
the price of generic drugs and capped the amount that the provincial government would pay
pharmacies for dispensing both generic and brand-name drugs. Additionally, Bill 102, the
Transparent Drug System for Patients Act, eliminated professional allowances and rebates that
pharmacists received to cover certain patient care initiatives (Grindrod, Sanghera, Rahmaan,
Roy, & Tritt, 2013; VanderElst, 2010). Community pharmacies had long relied on these
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allowances to cover the gap that existed between the actual cost and the amount paid by the
government for prescription drugs (Rosenthal, Austin, & Tsuyuki, 2012). Studies that sought to
examine the effects of the collective changes to the operational environment of community
pharmacies confirmed their detrimental impact on pharmacy operations and revenue (e.g.,
Rosenthal et al., 2012).
Given these legislative changes, the expanded scope of practice for pharmacists presented
new potential income streams as pharmacies began receiving remuneration from the provincial
government for the delivery of clinical services (Grindrod et al., 2013). For example, as part of
the management of medications, the Ontario Government introduced the MedsCheck program,
which allowed pharmacies to be compensated for performing comprehensive regular reviews of
patients’ medications and addressing any inconsistencies or concerns that arose from those
reviews by providing pharmaceutical treatment opinions to physicians (Grindrod et al., 2013).
Pharmacies also started receiving compensation for the delivery of vaccines and the
administration of other drugs such as methadone for the treatment of opiate addiction (OCP,
2012; OPA, 2014).
These new regulatory and financial realities of pharmacy practice rapidly transformed the
environment in which community pharmacies operated. Given that opting out of providing
services outlined within their expanded scope was not an option, pharmacists, despite their
extensive training, had to adapt and learn new skills as they began incorporating the delivery of
clinical services into their daily workflows (Nasra, 2018a). While the expanded scope of
practice’s main goal was to facilitate patient access to healthcare services, both the practitioner
community and governing bodies have admitted that the adoption and provision of these services
has been much slower than anticipated and not without its challenges, chief of which were the
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significant increase in pharmacist workload and insufficient resources (Nasra, 2018a; OPA,
2014; Silversides & Tierney, 2013). The need for more specialized support and assistance to
manage the increased demand on pharmacists quickly became evident as a critical point of
failure in this new operational environment and in response, the OCP formalized and introduced
a new regulated pharmacy support staff role, the Pharmacy Technician (PT) (OCP, 2015).
The PT role. Until 2010, pharmacy teams consisted of pharmacists and Pharmacy
Assistants (PAs) whose role was mostly clerical (Nasra, 2018a; OCP, 2012). In contrast, a PT’s
scope of practice encompassed managing all the “technical aspects of the prescription, the
gathering of patient information for the pharmacist to review, product preparation, product
distribution and inventory control” (National Association of Pharmacy Regulatory Authorities
[NAPRA], 2014, p.3; Williams, 2014). A comparison of the pharmacist, PA and PT roles is
presented in Table 1. Of important note is that the introduction of the PT role was not
accompanied by any legislative requirement to hire PTs, nor were there any efforts to formalize
or regulate the traditional PA role (Nasra, 2018a).
Table 1
Pharmacist, Pharmacy Technician, and Pharmacy Assistant Tasks
Task
Enters patient and
prescription information
Cashes out/ delivers
prescriptions
Completes filing tasks
Completes technical tasks
related to prescription
filling

Pharmacist
X

Pharmacy
Technician
X

Pharmacy
Assistant
X

X

X

X

X
X

X
X

X
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Table 1 (continued).
Signatory authority for
technical component of
prescription filling and
checking
Overall signatory authority
Patient counseling
Clinical services (e.g.,
immunizations,
prescription renewal)
Workflow management

X

X

X
X
X

X

As can be noted in Table 1, pharmacists are still ultimately accountable for the
therapeutic and clinical appropriateness of all prescriptions dispensed in the pharmacy (CPhA,
2015). Pharmacists are also able to perform all support staff tasks, and there is a significant
overlap between pharmacist and PT tasks as they pertain to dispensing medications, which is a
critical factor for the problem of practice that will be addressed in various sections of this OIP.
The Organizational Context from a Neoliberal Lens
Neoliberalism, which symbolizes a shift towards “greater marketization”, has become a
part of the modern lexicon (Bloom, 2017; Davies, 2014a). Despite its ubiquitous use, the term
neoliberalism, especially outside an economic context, remains relatively ambiguous which
could be attributed to the various perspectives of the theory that currently exist (cf. Clarke,
2008). While its origins emerged from the works of Friedrich Hayek in the 1930s and 1940s, and
later championed by Milton Friedman in the 1970s (cf. Mirowski & Plehweh, 2009), Harvey’s
(2005) conception of neoliberal philosophy best captures its essence and broad humanistic
implications. “Neoliberalism is in the first instance a theory of political economic practices that
proposes that human well-being can best be advanced by liberating individual entrepreneurial
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freedoms and skills within an institutional framework characterized by strong private property
rights, free markets, and free trade” (Harvey, 2005, p. 2).
Much of the criticism levied against neoliberalism stems from a specious utopian view
that self-interest alone can generate societal welfare, which is often conjured up with the image
of Adam Smith’s “invisible hand” that governs free markets and “whereby individual selfinterest produces generalized welfare” (Bloom, 2017, p.6). More recent reviews and examination
of neoliberal theory (e.g., Davies, 2014a; Gane, 2014) however, have shifted away from this
overly simplistic pro-market capitalist depiction, to a more complex and refined view in which
both the individual and the state play critical roles (Amable, 2011; Davies, 2014a) and are
enmeshed in all aspects of social life, and where fundamental social concepts such as morality
and ethics are also considered (Bloom, 2017; Harvey, 2005). While a thorough examination of
neoliberal philosophy is beyond the scope of this OIP, one key element that needs to be
highlighted is the role that the state/government plays in “creating markets” (e.g., through
privatization) and promoting standardization and self-regulation (Bloom, 2017; Davies, 2014a).
Neoliberalism does not dictate that governments should not have any role in the functioning of
the economy, what distinguishes neoliberalism from liberalism is the view that governments
“have certain functions to fulfill in order to make markets function … particularly marketenabling actions” (Biebricher, 2015, p.1).
Viewing the OIP’s context from a neoliberal perspective allows for a nuanced
understanding of some of the changes that the industry has experienced. As noted, the impetus
behind expanding the scope of practice for pharmacists and the regulation of the PT role was a
broader systemic increased demand on the provincial healthcare system that had become
unsustainable, inefficient and whose costs had spiralled out of control (Guirguis et al., 2014).
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While an ideal neoliberal approach to addressing this problem would have been to privatize
healthcare; the actions that the government has taken (i.e., expanding of the scope of practice for
pharmacists) also represents a form of privatization of some aspects of healthcare, or
“reinvent[ing] them in a ‘market-like’ way” which is in line with a neoliberal view (Davies,
2014a, p. 310). By taking on non-critical medical services such as renewing prescriptions,
managing the treatment of chronic disease, and providing vaccinations, hospital and clinic visits
could be reduced, decreasing the overall demand on the healthcare system while rendering those
services to patients more efficiently through community pharmacies (Bloom, 2017; Davies,
2014b). A consequence of this expanded scope of practice, described earlier, was the increased
demand for services in pharmacies, which meant that pharmacists, without the support of trained
support staff to assist them, bore the brunt of this increased demand (OPA, 2014; Silverside &
Tierney, 2013).
Given the importance of providing standardized, effective high-quality healthcare, one
could argue, from a neoliberal perspective, that these circumstances created the need for
government intervention in the form of creating the regulated PT role (Bloom, 2017; Davies,
2014b; Harvey, 2005). In line with a neoliberal view, this intervention stopped short of
interfering with pharmacy management’s ability to direct operations as they saw fit, hence no
legislation was imposed that mandated the hiring of PTs. Management, through careful
consideration of the costs and benefits, could determine the appropriate number of PTs to hire in
order to maximize efficiency and effectiveness while reducing costs. Moreover, once PTs were
hired, management could regularly monitor performance metrics both at the organizational and
individual level to ensure that standards and goals were being met.
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Alternatively, a neoliberal approach could also view governmental intervention as
interference in the operations of pharmacies, preventing them from naturally adapting to this
increased demand and perhaps finding more innovative cost-effective and efficient solutions
such as the automation of some tasks in the pharmacy (e.g., prescription filling). For the
purposes of this OIP, as will be elaborated in chapters two and three, some of the
recommendations that I put forth stem from this view that seeks to find efficiencies and
emphasizes the neoliberal tenets of self-regulation and standardization (Davies, 2014a).
Vision, Mission, Purpose and Goals
ParentCorp’s mission and driving purpose revolves around supporting the needs and
well-being of customers which is achieved by adhering to the corporate values of “care,
ownership, respect and excellence” (ParentCorp, 2018b). While my organization has obligations
to ParentCorp, both fiduciary and operationally, the independence afforded by the ParentCorp’s
franchise model enables my organization to maintain its own goals and core values that extend
beyond those of ParentCorp.
Given that my organization is entrusted with providing healthcare services, I strongly
believe that our responsibility is ultimately to the patient, regardless of their socioeconomic
status or background. While for-profit, my organization also believes in the moral obligation to
care for patients regardless of their socioeconomic status and their ability to pay. The expanded
scope of practice for pharmacists represents an important opportunity because it enables my
organization to care for patients using a holistic approach that goes beyond dispensing
medications. I also strongly believe in the importance of being good citizens, and as such my
organization is actively engaged in outreach initiatives to assist vulnerable groups in the
communities it serves. Staff are trained to care for patients seeking substance-dependence
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treatment, those who are HIV positive, those suffering from mental disorders as well as patients
with terminal illness. This type of engagement with patients reflects my organization’s values
and is centered on my belief in the noble mission of the profession of pharmacy (Nasra, 2018a).
Organizational Structure and Established Leadership Approaches
As per the OCP, leadership is one of the competencies that both pharmacists and PTs are
required to demonstrate (OCP, 2012). The two most senior leadership roles in the organization
are occupied by me, as a partner and Chief Human Resources Officer (CHRO), and by the other
partner who is also the Chief Pharmacist. As such, the great majority of organizational-level
leadership decisions rest with us. Given the highly regulated nature of the industry, clear lines of
authority are necessary. The need for accountability requires my organization to be hierarchical
in structure because leaders and management need to have the necessary oversight to ensure
regulatory compliance.
On a day to day basis leadership features greatly in the actual operation and functioning
of the pharmacy and is regularly practiced by pharmacy staff. The community pharmacy context
is relatively unique, with pharmacy operations being carried out by teams comprised of a
pharmacist and one or more support staff members (PT or PA) who work in shifts. During a
shift, one team is responsible for all aspects of the operation of the pharmacy, with the ultimate
authority residing with the pharmacist who holds the ‘official’ leadership role. The pharmacist on
duty is the sole decision-maker and is responsible for managing support staff and overseeing
their tasks. Given the nature of the organization’s work, the two most prevalent styles of
leadership that are exhibited are transactional leadership, and dyadic relationship-based
leadership (i.e., Leader-Member Exchange, LMX).
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Transactional Leadership. The highly task-oriented nature of both the pharmacist and
support staff roles means that a typical shift revolves around the organization and performance of
predetermined tasks. In that regard, pharmacists act as transactional leaders, setting explicit goals
that need to be accomplished. The emphasis and ultimate objective of each pharmacy team is to
achieve maximum efficiency while maintaining high standards of safety and service (Van Wart,
2013; Vera & Crossan, 2004). Given the highly regulated nature of the industry, standards of
practice, codes of conduct, and systems and processes are set out by regulatory bodies (e.g., the
OCP in Ontario), by ParentCorp, and by my organization.
As mentioned earlier, as franchisees, my organization has fiduciary obligations to
ParentCorp, and as such, most of the processes and systems that are in place are focused on
achieving efficiencies and increasing productivity. Mistakes, such as dispensing errors, are
documented and logged systematically and audits are regularly performed by regulatory bodies.
Employees who violate any of the set processes are reported and/or sanctioned. The regular
performance of tasks that are repeated in every shift leads to established routines and workflows
which are ultimately derived from basic standard operating procedures (SOPs). All the above
factors contribute to a highly transactional environment exhibiting all the hallmarks of
transactional leadership (Hackman & Johnson, 2013; Judge & Piccolo, 2004).
Leader-Member-Exchange. As indicated above, during each shift, the pharmacist and
support staff work in conjunction, with the pharmacist taking on the official leadership role and
the support staff (PT or PA) taking on the subordinate/follower role. This relationship-based
dynamic is built on dyadic interactions between leader and follower which exhibit several
hallmarks of LMX leadership theory (Bauer & Erdogan, 2015; Graen & Uhl-Bien, 1995).
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Research and internal data suggest that pharmacists exhibit a more pronounced sense of
trust and respect for PTs than PAs (Bauer & Erdogan, 2015; Bullock, Allan, Barnes, Hodson, &
Russ, 2016; Deluga, 1998; Nasra, 2018a; Organization X, 2016b, 2017b). This can be explained
in part by the technical knowledge that a pharmacist and a PT share because of their education,
and because of the ability of pharmacists to delegate some of their responsibilities to PTs. The
beginning of the task delegation process typically involves a stage where the pharmacist mentors
and teaches the PT as to their preferred method of doing things. Internal data, as well as research
findings, have also revealed that pharmacists describe their relationship with PTs as being more
collaborative than with PAs where they view their role as being more supervisory (Bradley,
Schafheutle, Willis, & Noyce, 2013; Bullock et al., 2016; Nasra, 2018a; Organization X, 2016b,
2017b). This differential treatment can potentially result in PAs feeling undervalued, as well as
the creation of “in groups” and “out groups” which have been examined in LMX literature
(Erdogan & Bauer, 2014; Graen & Uhl-Bien, 1995). In chapter two, I put forth a framework for a
proposed leadership approach that combines critical aspects of both Transactional Leadership
and LMX and elaborate on how emphasizing both structural and relational elements of
leadership are fundamental to my OIP.
Leadership Position and Lens Statement
Leadership is complex, but it is also personal and idiosyncratic. Drenkard (2012) stated
that “the genius of leadership lies in the manner in which leaders see and act on their own and
their followers’ values and motivations” (p. 148). Succinctly put, my leadership philosophy is
about empowering and engaging my employees in the pursuit of my organization’s vision and
goals. Only by empowering followers can a leader achieve meaningful outcomes. I strongly
believe that an effective leader is one who enables his/her followers to reach their full potential
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and in doing so, also enables organizational success (Maxwell, 2007; Nasra, 2018a). An
examination of the values and behaviours that drive my leadership reveals an alignment with
some tenets of authentic and adaptive leadership theories. While the leadership approach I
propose in this OIP is not based on these theories, as will be discussed in chapter two, there are
key relational elements that are shared by these leadership styles, especially as they pertain to
outcomes such as trust and engagement.
Gardner, Avolio and Walumbwa (2005) state that “authenticity involves both owning
one’s personal experiences … and acting in accordance with one’s true self” (pp. 344-345).
Authenticity to me is not only about the congruence between one’s own experiences and actions.
What is critical, I believe, is the self-awareness and introspection that authenticity requires. Kurt
Vonnegut wrote “[w]e are what we pretend to be, so we must be careful about what we pretend
to be” (2009, p.v). This quote resonates with me because I believe that no matter how hard we
try to be true to ourselves in a work setting, especially as leaders, it is not always possible to be
truly authentic all the time. As such, equally important is being mindful of who I project myself
to be in front of my followers. Mindfulness involves “[p]aying attention on purpose, in the
present moment” (Kabat-Zinn, 2005). As such, I believe that the more mindful and self-aware I
am as a leader, the more likely I am to be authentic, relatable and trustworthy (Nasra, 2018a).
I believe that leadership is situational and successful leadership needs to be adaptable and
flexible (Nasra, 2018a). Dealing with a complex operational environment, as many organizations
do, requires constant analysis, recalibration and agility to ensure that both the leader and the
organization are responding to changes, threats and opportunities in a timely manner. As such,
introspection, reflection and mindfulness also play an integral role because by constantly paying
attention to the present situation, a leader can objectively see what is or isn’t working and adjust
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accordingly (DeRue, 2011; Heifetz, Grashow, & Linsky, 2009). In doing so, a leader can make
necessary changes and adjustments as needed and identify potential problems before they
become major obstacles (Sauer & Kohls, 2011). I believe that this adaptability builds resiliency
within the organization and contributes to success in the long term. My leadership philosophy,
values, beliefs and assumptions reflect my current view of the world we live in; one where
complexity and rapid change are becoming the norm. Complexity and change require that leaders
adapt, accept, and learn from failure and develop a better awareness of the people they work with
and the environment the organization operates in. The change plan that I detail in chapter three
highlights this critical need for evaluation and recalibration through careful monitoring of how
change is unfolding in the organization.
As indicated at the beginning of this chapter, the approach that has informed my OIP is
rooted in a neoliberal perspective that emphasizes efficiency, self-regulation, and standardization
(Bloom, 2017; Davies, 2014b). These constructs are inherently tied to structural elements and
conditions both within the organization and its operational environment. To best understand the
variables that influence the problem of practice, it is therefore important both from an analytical
and a theoretical perspective to frame the problem of practice by focusing on the structural
dynamics and forces within the organization. To that end, after summarizing and stating the
problem of practice below, I make use of Bolman and Deal’s (2013) organizational analysis
framework, more specifically the structural frame as a lens through which critical insights about
my organization can be gleaned and understood.
Leadership Problem of Practice
As CHRO and partner in Organization X, a pharmacy services company that currently
owns and operates two community retail pharmacies in Ontario, it is my responsibility to ensure
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that our pharmacies properly adapt to the aforementioned changes in the industry (Nasra, 2018a).
Since the introduction of PTs and the expansion of the scope of practice for pharmacists, my
organization has observed several concerning outcomes such as: higher rates of dispensing errors
and incidents impacting patient safety, lower customer satisfaction and decreased employee
engagement (Organization X, 2016a, 2016b, 2017a, 2017b). As such, my problem of practice
seeks to address the negative impact on organizational performance and customer service
resulting from recent legislative changes that have expanded pharmacists’ scope of practice
(Nasra, 2018a).
Framing the Problem of Practice
The historical evolution of the problem of practice, as outlined earlier, reveals that
pharmacy practice in Ontario, across Canada (Gregory & Austin, 2017; Lynas, 2011), and in
other western countries (e.g., Koehler & Brown, 2017) is undergoing a major paradigm shift. In
this section, using Bolman and Deal’s (2013) organizational analysis framework, specifically the
structural frame, I examine the multilevel factors that influence and shape the problem of
practice. I follow this with a brief overview of the recent literature on the topic. Both these
efforts involve an examination of the political, economic, social and technological (PEST)
factors that are relevant to the problem of practice, which are summarized at the end of this
section in Table 2.
Bolman and Deal’s (2013) Organizational Analysis Framework
In their seminal work, Bolman and Deal (2013) synthesized organizational theory’s major
schools of thought into their four-frame approach for analysing organizations. Broadly speaking,
a frame is “a mental model; a set of ideas and assumptions” through which individuals view and
make sense of organizations and situations (Bolman & Deal, 2013, p. 11). As per Bolman and

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

16

Deal (1991), frames are also “preconditioned lenses and filters” that enable organizational
leaders to process information about their organizations, further enhancing their understanding.
Bolman and Deal (2013) put forth four such frames or lenses through which organizations could
be viewed: structural, human resources, political, and symbolic.
While each of the four frames provides unique insights and understanding of the
organizational dynamics and processes underlying my problem of practice, the analysis below is
limited to the structural frame given the high degree of alignment between its assumptions,
imperatives and dilemmas and my organization’s current state (Bolman & Deal, 2013; Nasra,
2018a), as well as its complementarity with the neoliberal perspective (Davies, 2014b).
The structural frame. As a healthcare provider, my organization is part of a highly
regulated industry where an emphasis on standards of practice is part of organizational reality. In
addition to the oversight through standards developed by governing bodies, such as the OCP and
the Ontario Ministry of Health and Long-Term Care, additional levels of oversight are enabled
through both ParentCorp’s policies as well as internal guidelines (Nasra, 2018a; ParentCorp,
2018b). This type of control is a key feature of the structural frame (Bolman & Deal, 2013).
The structural frame and neoliberal perspectives emphasize rationality and efficiency
(Bolman & Deal, 2013; Brown, 2003; Davies, 2014b; Harvey, 2005; Lemke, 2001). While
maintaining efficiency is key in the organization, it is a far cry from the rigid control that Taylor
(1911) had envisaged or from Weber’s “monocratic bureaucracy” (Weber, Roth, & Wittich,
1978). Efficiency’s main goal is not intended to solely improve financial outcomes, but is geared
towards providing optimal customer service, ensuring that patients access their medications in a
timely fashion, and providing clinical and counseling services as needed.
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The structure of an organization “both enhances and constrains what an organization can
accomplish” (Bolman & Deal, 2013, p. 50). Constraint, in my organizational context manifests at
all levels of the organization. From a macro-perspective, healthcare in general and pharmacy
practice specifically, carries with it ethical and moral obligations that require oversight,
compliance, and regulation to ensure patient safety. This is in line with a philosophical theme
where bureaucratic organizational models, with their division of labour, administrative
regulations, and clearly established lines of authority and hierarchy play a critical role in
organizational functioning (Du Gay, 2000; Weber, et al., 1978). However, bureaucratic and
institutional rigidity can also act as an “iron-cage” that prevents the organization from fulfilling
its obligations towards another key group; its shareholders (Adler, 2012; DiMaggio & Powell,
1983; Mitzman, 1985). Community pharmacies in Canada are privately-owned for-profit entities
that are accountable to their shareholders and have an obligation to exploit growth opportunities,
reduce operating costs, and maximize profits. Seen through this lens, regulations and
bureaucratic structures are obstacles towards the attainment of these organizational goals, a
sentiment that is echoed in neoliberal thought (Davies, 2014a).
At the micro-level, constraint, given the problem of practice, is ironically desirable
because while each pharmacy team during a shift is expected to function autonomously, the
amount of discretion that is afforded to employees is limited by their scope of practice. Viewed
from this perspective, rules and structure serve as protection or control mechanisms that
minimize errors and ensure patient safety. They however can also hinder efficiency and
productivity, and one key challenge for the OIP is therefore to strike a balance in terms of
constraint to ensure that rules and structure leverage and enhance employee effort by facilitating,
instead of hindering it (Adler & Borys, 1996). In other words, one of the key objectives for the
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OIP will be to ensure that the “social architecture” of the organization is aligned with its mission,
values, and goals (Bolman & Deal, 2013; Jones, Hesterly, & Borgatti, 1997; Lepak & Snell,
1999; Nasra, 2018a).
Structural tensions and dilemmas. A full assessment of the structural dilemmas and
tensions in my organization as per the structural frame is not possible given the space limitations
of this chapter. As such, I will address the most relevant elements of the analysis below.
Differentiation vs. integration. The division of labour, the differentiation of employee
roles, and the integration of efforts features greatly both in the structural frame as well as my
problem of practice (Bolman & Deal, 2013; Nasra, 2018a). Since the introduction of the PT role,
internal organizational data has revealed concerns directly related to these issues (Organization
X, 2016a, 2017a). As noted earlier, pharmacy teams are comprised of three ‘types’ of employees
with highly differentiated roles: pharmacists, PAs, and PTs. On any given day, a pharmacy team
can be comprised of a pharmacist working with either a PT or a PA (Nasra, 2018a). As noted
earlier, pharmacists can only delegate tasks to PTs but not PAs (see Table 1). Given the fastpaced and highly task-oriented nature of the work, the frequent adjustments in the workflow that
pharmacists must undertake depending on who they are working with often leads to suboptimzed
performance (Bolman & Deal, 2013).
Vertical and lateral coordination. Pharmacy teams operate as units and are expected to
function autonomously during a shift, without having to resort to the Chief Pharmacist or senior
management except for emergencies. Authority in a pharmacy team rests with the pharmacist
who is the de-facto leader during a shift (Nasra, 2018a). That said, pharmacists and support staff
must abide by rules, policies, regulations and standards that are set by the OCP, ParentCorp, as
well as senior management in the organization. Senior management, myself included, put in
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place performance plans and control systems that are intended to optimize performance as well
as meet operational goals. For example, there is a specific number of medical reviews that the
pharmacy team is required to perform per shift, in addition to meeting other performance metrics
(e.g., amount of time to fill a prescription), both of which are examples of controlling
performance (Mintzberg, 1979).
Lateral coordination is key in the functioning of pharmacy teams. At the beginning of
each shift, huddles take place to address and review expectations. Short handoff meetings
between incoming and outgoing staff members are also conducted. To ensure the seamless
transition between shifts, an overlap in support staff is deliberately designed into the schedule.
While this does result in suboptimization of performance from a cost perspective, these overlaps
enable support staff to act as boundary-spanners, ensuring that performance gaps between the
transitioning teams are minimized (Bolman & Deal, 2013, p. 57; Dollinger, 1984; Williams,
2002). This lateral coordination and overlap also improves workflow as the support staff is aware
of any areas that require attention such as existing delays in processing prescriptions. As
highlighted earlier, improper lateral coordination within pharmacy teams, such as delegating
tasks to PAs, is one of the challenges facing my organization (Nasra, 2018a).
Excessive autonomy vs. excessive interdependence. Each pharmacy shift acts as a
standalone unit operating with high autonomy. These units can also be described as self-managed
teams (Bolman & Deal, 2013). There is a high degree of interdependence between team
members. A lack of coordination/integration of efforts, such as a pharmacist taking too long
during counseling sessions, or support staff falling behind in entering prescriptions into the
computer system, can lead to suboptimal performance and chaos. Even though it is unavoidable,
this excessive interdependence of team members represents a risk and requires a high level of
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communication, leadership and learning given the high-paced nature of the work being
performed (Bunderson & Boumgarden, 2010; Zarraga & Bonache, 2005). Moreover, the
excessive autonomy that these teams enjoy can lead to issues for the shift that follows. With each
pharmacy team acting as a self-managed, standalone unit that is focused on getting through their
shift, teams often leave a backlog of work for the team that follows. Rather than consider the
pharmacy’s overall performance, group members sometimes focus too much on getting through
a shift and providing the best care possible, that ensuring continuity and optimal workflow are
over-ridden by the insularity of the shift despite having support members acting as boundaryspanners to minimize those effects (Nasra, 2018a). These themes relating to the work of
pharmacy team members will be revisited in the critical organizational analysis conducted in
chapter two.
Structural imperatives. Bolman and Deal (2013) highlight that each organization “needs
to respond to a universal set of internal and external parameters”; what they refer to as structural
imperatives (p. 62). These include size, core processes, environment, strategy and goals as well
as the nature of the workforce. In my organization, pharmacy teams are small, which makes them
typically simpler to manage. The high interdependence of team members, coupled with a high
degree of role differentiation (i.e., the inability of support staff to take on pharmacist tasks) and a
high degree of role overlap (see Table 1), however, increases the structural tensions within the
organization and represents multiple points where one team member’s performance can lead to
failure. The core processes of the pharmacy team are highly defined, but complex in nature. The
high diversity in the types of tasks that pharmacists undertake is an extreme challenge that also
slows down performance as pharmacists shift from one type of task to another (e.g., counseling
patients, verifying prescriptions, managing workflow). The environment as described above is
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highly paced and despite the routinized nature of the tasks, shifts can be extremely unpredictable,
especially when dealing with patients whose treatment requires additional attention (e.g., drug
dependence) (Nasra, 2018a).
Recent Literature - Multilevel Factors Impacting the Problem of Practice
The literature on the impact of legislative and regulatory changes in pharmacy remains in
its infancy and scholarly studies are relatively limited and largely focus on the challenges and
outcomes of these significant changes in pharmacy practice. A comprehensive and systematic
review of the literature on the changing scope of pharmacy practice initially revealed two broad
themes: the barriers and challenges to the implementation of change, and the outcomes of
change. As I elaborate below, most of the challenges and outcomes were found to be related to
the perceptions, attitudes and behaviours of different stakeholders in the organization, and are a
direct reflection of the central meso and micro discourses that shape the problem of practice.
At the core of the micro symbolic-interactionist perspective is how individuals
understand and ascribe meaning to their reality through social interactions (Blumer, 1980).
Examining the root causes of the poor integration of PTs in pharmacy teams necessitates such
micro-level inquiry and analysis. Moreover, such an examination can elucidate the changing
social dynamics within pharmacy teams, as well as with patients. As stated earlier, organizational
data suggests that patients often fail to distinguish between PAs and PTs and expect the same
level of knowledge and service from both (Organization X, 2016a, 2017a). An assessment of
organizational surveys also reveals that PAs feel pressured to counsel patients on health matters
for which they are not trained, and they do so to avoid complaints and low customer satisfaction
ratings (Organization X, 2016b, 2017b). This not only represents a grave concern for the wellbeing of patients, but also serves to highlight the importance of examining the meaning and
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assumptions that people derive from their experiences, exchanges and environmental cues
(Blumer, 1980; Carter & Fuller, 2016). It is interesting to note that these effects have also been
reported in the literature as described below.
The pharmacist perspective. Shifting from a product-focused/business-oriented role to a
patient-focused/clinical-oriented role, as operationalized by the expanded scope of practice,
essentially redefined the pharmacist role in the provision of healthcare products and services, and
as such, it was not surprising that the key challenges and concerns that arose from this paradigm
shift were related to role perceptions (Perepelkin & Dobson, 2009). The literature revealed that
pharmacists in North America and Western Europe, for the most part, still consider their work in
community pharmacies to be “for profit” and still view their interactions as taking place with
customers or clients instead of patients (Austin, Gregory, & Martin, 2006; Perepelkin & Dobson,
2009). In the community pharmacy field, there has been a long-standing tension and uncertainty
in the professional orientation of pharmacists between their healthcare and business roles, which
was further heightened by the expanded scope of practice of pharmacists (Perepelkin & Dobson,
2009).
According to Austin et al. (2006), the use of terms such as patient, client, customer, or
consumer in pharmacy practice carries with it different interpretations of pharmacists’ roles and
responsibilities, as well as varying perceptions of pharmacists’ autonomy and hierarchy in the
organization which can have a significant impact on pharmacists’ interactions with the people
they serve. Interestingly, recent studies suggest that pharmacists, despite their expanded scope of
practice, still view themselves mainly as ‘dispensers of medication’ rather than as health care
professionals (Rosenthal, Breault, Austin, & Tsuyuki, 2011). This belief is perhaps further
reinforced by the fact that despite changes in remuneration practices, volume-based dispensing
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of drugs continues to be considered by many organizations as a more stable and lucrative source
of income than providing clinical services in the pharmacy (Rosenthal, et al., 2011).
Other challenges that pharmacists face that were also examined in the literature included
concerns pertaining to perceptions of the social legitimacy of their profession given its wellestablished business-orientation; concerns about overlapping roles and responsibilities with
physicians; as well as concerns regarding patient reactions which prevented pharmacists from
offering clinical services to patients even when they believed they could be of benefit (Beales &
Austin, 2006; Guirguis et al., 2014). These findings appear to suggest that the long-dominant
business mindset has caused harm to the professional image of community pharmacists as
healthcare providers, from the perspective of pharmacists, patients and other members of the
healthcare industry (Beales & Austin, 2006).
A few studies however did report some positive pharmacist perceptions and attitudes
regarding their expanded role. For example, Makowsky, Guirguis, Hughes, Sadowski, and
Yuksel (2013) found that pharmacists believed that there were important benefits to their new
prescriptive authority such as the optimization of a patient’s treatment during their physician’s
absence. Pharmacists also reported an increased sense of professionalism as health care
providers, increased job satisfaction, and an overall improvement of their professional
knowledge (Makowsky et al., 2013). In fact, confidence in clinical knowledge was found to be
one of several critical factors that impacted pharmacists’ willingness to exercise their
prescriptive authority (Roberts, Benrimoj, Chen, Williams, & Aslani, 2006). Other factors
included autonomy, access to local networks of colleagues and external support (Roberts et al.,
2006).
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The support staff perspective. During each shift, pharmacists and support staff work in
close conjunction during the performance of their tasks (Nasra, 2018b). Even though the
introduction of the PT role was meant to delegate technical tasks to PTs, the drug dispensing
process still requires close collaboration and effective teamwork between the pharmacist and the
PT, as they have complementary responsibilities for drug therapeutic appropriateness and
technical accuracy, respectively (Nasra, 2018b). As a result, dissociating these two activities
completely has been a challenge that has hindered the ability of the PT to relieve pharmacists’
time which could be otherwise dedicated to patient care and the provision of clinical services
(Frost & Adams, 2017; Koehler & Brown, 2017; Lynas, 2011).
Beyond challenges relating to workflow, research findings also appear to suggest that
pharmacists exhibit a more pronounced sense of trust and respect for PTs than for PAs which can
be explained in part by the technical knowledge that a pharmacist and a PT share because of their
formal training (Bullock et al., 2016). Pharmacists also tend to view their relationship with PTs
as being more collaborative in nature whereas their role with PAs as being more supervisory
(Bullock et al., 2016). This differential treatment has been linked to lower levels of job
satisfaction for PAs and other support staff who may feel undervalued (Inoue et al., 2016). These
findings appear to be somewhat perplexing because despite valuing the role of PTs and their
training, Bullock et al. (2016) found that the great majority of pharmacies looking to hire new
support staff were more inclined to hire PAs than PTs. Moreover, Schafheutle, Samuels, and
Hassell (2008) found that while pharmacists had positive attitudes towards PTs, they still did not
delegate tasks that could be carried out by PTs or other support staff.
It was not surprising that the expanded scope of practice, and the introduction of the PT
role were also found to be related to increased conflict among pharmacy team members. A recent
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study by Gregory and Austin (2017) found that changes in the practice were related to role
misunderstanding, threats to one’s professional self-identity and workplace demotivation. These
outcomes could be attributed in part to personal differences, knowledge gaps, and a general lack
of information sharing between pharmacists, PTs, and PAs (Gregory & Austin, 2017) which
highlights the importance of considering the impact of regulatory changes from a human
resources perspective (Cooper & Mohr, 2006).
The patient perspective. Characterizing the relationship between pharmacists and those
they serve is an important step in ensuring that the profession has shifted to a patient-oriented
practice and that it is fulfilling the healthcare needs of society (Austin et al., 2006). A 2004 study
conducted in Ontario suggested that, “in general, people who are served by the pharmacist do not
see themselves as patients, but instead consider themselves to be customers or clients” (Verbeek,
2004, as cited in Austin et al., 2006; Guirguis et al., 2014). This is significant for several reasons.
Firstly, because it mirrors the same difficulty that pharmacists are experiencing in terms of their
own self-perceptions, as indicated previously. Additionally, current regulations and legislation
do not address the impact that changes in the provision of healthcare services have on their
consumers. Interactions between a pharmacist and those seeking their products and services are
dyadic and a major change that impacts the core function of one side of the interaction (i.e.,
pharmacists) which does not consider the other party (i.e., patients) will likely lead to a
misalignment in expectations (Austin et al., 2006; Nasra, 2018b). Perepelkin and Dobson (2009)
further highlighted the detrimental impact of the public’s ambiguous interpretation of the role of
pharmacists, which they found vacillated between viewing pharmacists as healthcare
professionals and seeing them as nothing more than business owners. The latter view can
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significantly impede attempts to provide clinical services, as the public may consider that
pharmacists are only doing so to benefit their bottom-line (Guirguis et al., 2014).
Research into patient perceptions also revealed that the majority could not distinguish
between trained pharmacists and PTs, and that they erroneously assumed that all support staff,
including PAs, were equally knowledgeable and capable of addressing queries related to
medications (Sheridan, Kelly, Basheer, Jan, & Lee, 2011).
Table 2
PEST Analysis
Factor
Political

Economic

Social

•
•
•
•
•
•

•
•
•
•
•
•
•
•

Technological

•
•
•
•
•

Application to Organizational Context
Expanded Scope of Pharmacist Practice (Bill 179)
Transparent Drug System for Patients Act (Bill 102)
Pharmacy Technician role regulation
Tension between need for generating profit and
delivering public services
Reduced revenue from prescriptions (Bill 102)
Revenue generated from billable clinical services:
o Immunizations
o Medscheck program
o Rx renewal
PTs more expensive to hire than PAs as support staff
Corporate company budget restrictions
Financial performance metrics
Role overlap between Pharmacists and PTs
Patient perceptions; inability to distinguish between
support staff
Transactional exchanges between pharmacists and
support staff
Support staff feeling undervalued
LMX: formation of ingroups (PTs) and outgroups (PAs)
due to differential leader treatment
Workflow adjustments depending on whether pharmacist
is paired up with PA or PT during shift
Pharmacists not delegating technical tasks to PTs
Pharmacists delegating tasks to PAs
Highly task-oriented work setting
Standard Operating Procedures not updated to consider
evolving support staff roles
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Guiding Questions Emerging from the Problem of Practice
While this OIP’s main focus and emphasis is my organization, the concerns raised by the
problem of practice are not unique to it. The operational environment, more specifically the
legislative and regulatory framework that my organization operates under, impacts all
community pharmacies in Ontario, in other provinces as well as some countries where similar
legislation exists (e.g., Austin et al., 2006; Perepelkin & Dobson, 2009). The problem of practice
deals with a fundamental shift in pharmacy practice. Unfortunately, public data is not available
to conduct a comparative analysis and explore whether other pharmacies are experiencing similar
issues. The review of the academic literature, however, does provide some evidence that the
questions raised in this OIP are shared by other organizations, and that the impact of the
changing forces in pharmacy practice may be similar to what my organization is currently
experiencing (e.g., Perepelkin & Dobson, 2009; Sheridan et al., 2011). As such, one emerging
question that is useful for my OIP is: are there benefits from considering the problem of practice
more globally as opposed to focussing solely on my organization? In a similar vein, given the
wider implications for community pharmacy practice, is there a need for the concerns raised by
this OIP to be elevated and brought to the attention of governing bodies such as the OCP or the
Ontario Ministry of Health and Long-Term Care so that more comprehensive large-scale studies
could be conducted? While this OIP unfortunately cannot tackle these important questions, they
do help guide my thinking and analytical approach by contextualizing and embedding this OIP
within its broader operational and social context. For instance, in conducting the critical
organizational analysis in chapter two, it is essential that I consider all impacted stakeholders,
both internal (i.e., employees) and external (i.e., patients). It is also essential that the chosen
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solution be comprehensive and address all aspects of the problem of practice in order to
maximize its chances of affecting meaningful change.
Another guiding question for my OIP relates to the solutions that I can pursue, and the
tension that exists between my organization’s private for-profit orientation, and the delivery of
public, and sometimes government-funded, healthcare products and services. Given the
limitations imposed by legislation and regulations, as well as the demands for profitability
dictated by shareholders, how can I balance these opposing dynamics and at the same time come
up with effective solutions that address my problem of practice? In other words, how do I tackle
a complex issue with serious implications while remaining within a relatively small sandbox
whose margins are imposed by public and private imperatives and demands? As will be noted in
the critical organizational analysis in chapter two, this is an important and recurring question that
manifests itself as an underlying theme for this OIP. One important implication for this question
is that I could be limited in the scope of the changes that can be pursued, or that the solutions
available to me may not be the most efficient or effective ones as identified by the organizational
analysis.
The implications of these emerging questions become even more evident as I begin to
formulate this OIP’s vision for change and describe the current gaps and priorities for change in
this following section.
Leadership-Focused Vision for Change
Organizational State and Gaps
Since the introduction of the expanded scope of practice for pharmacists and the
regulation of the PT role, internal organizational data, such as customer satisfaction surveys,
employee engagement questionnaires as well as audit and incident reports, have revealed several
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concerns summarized below (Organization X, 2016a, 2016b, 2017a, 2017b). These concerns
represent the major gaps in organizational state that this OIP seeks to address.
Workflow adjustments. Pharmacists who work with PTs can delegate some of their
responsibilities (i.e., the technical aspects of prescription filling and validation) to PTs. However,
due to the higher costs of hiring PTs (ParentCorp, 2018c), most of the support staff in our
pharmacies, and most community pharmacies, are PAs (Bullock et al., 2016). As such
pharmacists tend to be paired up with PAs frequently. When a pharmacist works with a PA, they
need to adjust their workflow because task delegation cannot take place.
The need to manage support staff differently on a regular basis depending on who a
pharmacist works with during a shift poses a major challenge for a profession that is extremely
task-oriented and fast-paced, and has been linked to pharmacist dissatisfaction (Lin, Leu, Breen,
& Lin, 2008). Internal data, as well as research findings reveal that pharmacists often do not
delegate any of the technical tasks to PTs when working with them in an effort to remain
consistent and maintain the same workflow that they are accustomed to when working with PAs
(Angelo & Ferreri, 2005; Organization X, 2016b, 2017b; Schafheutle et al., 2008). A more
serious but related outcome of trying to avoid ‘shifting gears’ is the opposite scenario: some
pharmacists who like the efficiencies achieved while working with PTs have been delegating
technical tasks to PAs, who are not trained nor legally allowed to perform such tasks
(Organization X, 2016b, 2017b). Internal data reveal that the consequences of workflow
adjustments range from PTs feeling undervalued and unchallenged when their skills are not
being utilized appropriately, to errors and potential legal violations because PAs are performing
tasks beyond the scope of their expertise and training (Organization X, 2016b, 2017b). It is
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important to note that these findings mirror those that have been reported by researchers in the
literature (e.g., Gregory & Austin, 2017; Hoxsie, Keller, & Armstrong, 2006; Inoue et al., 2016).
A different level of service. Given that PTs are highly trained, they can address many of
the technical questions regarding a patient’s prescription (NAPRA, 2014). Patients have come to
expect the same level of expertise from support staff and are usually not aware of the knowledge
differences between PAs and PTs (Organization X, 2016a, 2016b, 2017a, 2017b; Perepelkin &
Dobson, 2009; Sheridan et al., 2011). As a result, since the introduction of the PT role, internal
organizational data revealed a significant decrease in customer satisfaction ratings for PAs in
feedback surveys, often noting that PAs were not knowledgeable or helpful, in addition to higher
rates of complaints lodged against PAs (Organization X, 2016a, 2016b, 2017a, 2017b). PA
feedback survey responses suggest that PAs felt pressured to answer patient questions and to
provide medical advice beyond the scope of their knowledge (Organization X, 2016b, 2017b).
While the variability in the service that a customer can expect when they are being attended to is
a significant source of concern to my organization, providing unqualified medical advice is a
serious ethical violation that can endanger patients’ health and have severe consequences.
Priorities for Change
Addressing the core concerns raised in my problem of practice requires behavioural,
structural, and process-based changes which will be integral to this OIP. More specifically, the
issues below, which emanate from the current gaps in the organization, represent the
organization’s main priorities for change:
•

Modifying and optimizing current workflows in the pharmacy to ensure efficiency
and adaptation to the new PT role;
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Formalizing the role of PTs in the pharmacy team to best utilize their skillset and
ensure their proper integration; and

•

Engaging with the public about the roles that different pharmacy team members play
as well as the clinical services that are available to them.

These priorities will be at the core of the detailed organizational change plan and
recommendations that will be put forth in chapters two and three. These priorities also represent
the key to balancing the needs of both internal and external stakeholders. For example, the
modification and optimization of pharmacy workflows will focus on ensuring patient safety
while at the same time maintaining efficiency. Similarly, engaging with patients will not only be
beneficial in terms of educating them about the functions of the pharmacy, but will also
explicitly address issues related to role perceptions, which were summarized in the literature
review, and which could help mitigate some of the behaviours that have contributed to the
problem of practice.
Change Drivers
Kotter’s (2012) change model highlights the importance of “building a guiding team”
within the organization. For a change initiative to be successful it is critical to have champions
who act as change drivers within the organization. In my organization, this guiding team would
consist of myself, the other partner and Chief Pharmacist, as well as representatives from our
pharmacist and support staff cadres. Involving employees at every step of the OIP will set the
stage for these organizational members to act as change agents (Cawsey, Deszca, & Ingols,
2016) who help facilitate buy-in and create a sense of engagement and ownership over the
change initiative (Hoadley & Lamos, 2012).
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With the guiding team taking on a leadership role, it is essential to develop a clear vision
of where the organization needs to be (i.e., the future desired state). Putting forth an achievable
vision that is agreed upon by various stakeholders and that embodies the organization’s values
and goals also helps achieve a shared organizational understanding of the overall change
initiative and can galvanize all stakeholders in support of those goals (Calegari, Sibley, &
Turner, 2015). In addition to being change agents, having representatives from every employee
group in the leadership team can further facilitate the change effort by monitoring progress and
identifying the core challenges that may arise throughout the implementation of the OIP (Nasra,
2018a).
Organizational Change Readiness
Change initiatives, no matter how well-planned, can be derailed if an organization is not
ready for change. The factors that have precipitated the organization’s current state, as well as
those that have contributed to symptoms of the problem of practice, are structural and social in
nature and they originate from both outside and within the organization. It is not surprising
therefore that when assessing an organization’s change readiness, both internal and external
forces need to be examined, and that systems and people are fundamental to such an assessment
(Cawsey et al., 2016; Freeman, Wicks, & Parmar, 2004; Judge & Douglas, 2009).
Armenakis, Harris, and Mossholder (1993) highlight that change readiness is reflective of
organizational members’ “beliefs, attitudes, and intentions regarding the extent to which changes
are needed and the organization’s capacity to successfully make those changes” (p. 681). In my
organization, this highlights the importance of engaging the key stakeholders in the change
process and ensuring their buy-in and active participation (Holt, Armenakis, Field, & Harris,
2007; Kotter, 2012; Kotter & Cohen, 2002; Lewis, 2019). While the organization’s financial and
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operational performance (e.g., dispensing error rates) is certainly important for shareholders and
ParentCorp, the problem of practice’s implications are clearly manifested and can be directly
observed at the individual level, with pharmacists and support staff being the key players that
will be impacted by the change initiative. It is essential therefore that the OIP carefully considers
not just the organization’s, but also the individuals’ readiness for change (Cawsey et al., 2016;
Weiner, 2009).
In my organization, it may seem ‘evident’ for the management and leadership team that
change is necessary. Increased demands on pharmacists, the poor integration of pharmacy
support staff, and higher error rates are all indicators that all is not well. Leadership, however,
should not take for granted that organizational members will simply be on-board, or that they
inherently understand “why” change is necessary (Beckhard & Harris, 1987; Cawsey et al.,
2016). The complexity and multi-dimensional nature of organization change is further
highlighted by Judge and Douglas’s (2009) model for assessing an organization’s capacity for
change. Judge and Douglas (2009) suggest that eight separate but correlated dimensions impact
organizational change readiness: trustworthy leadership; trusting followers; capable champions;
involved middle management; innovative culture; accountable culture; effective
communications; and systems thinking. These dimensions highlight the comprehensive and
complex nature of organizational change, and how critical it is that organizations adequately plan
and prepare for it.
Part of preparing for organizational change is understanding the internal and external
forces that are currently at play and can shape and determine the outcomes of the change
initiative (Cawsey et al., 2016; Holt et al., 2007). While internal and external forces may imply
that they are in “opposition”, in truth, any such force may have the ability to facilitate, constrain
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or block change efforts (Cronshaw & McCulloch, 2008). It is therefore imperative for this OIP to
examine in detail the impact that each force will have.
From an external perspective, the most dominant forces that will inform, and to a certain
degree constrain, the change plan include the provincial and governing body regulations that
impose restrictions and obligations on the pharmacy as a whole, and on the role that each
pharmacy staff member can play. As such, it will be important to examine the scope of what
possible and meaningful change looks like within the confines of what has been prescribed by
regulatory bodies and government policies. Similarly, operational guidelines that are set by
ParentCorp, as well as budgets and fiduciary obligations will also have a significant impact on
any change plans. For example, hiring new support staff members, or changing the composition
of pharmacy teams will be limited to the extent that the organization’s operational budget
permits it. Finally, as was evident in the review of the literature, one cannot underestimate the
role that patient perceptions, attitudes, and expectations will have on any change in the
organization. As was highlighted earlier, the introduction of the PT staff resulted in the confusion
of patients who could not differentiate between PTs and PAs, which precipitated some of the
unintended consequences of this change (Sheridan et al., 2011). As such, any proposed changes
in the pharmacy will need to take into account how they will be received, and perceived, by the
public and whether any additional measures need to be put into place, such as communication or
information campaigns, to counteract any potential problems.
Internally, the most important forces that the OIP needs to take into account are employee
perceptions and attitudes. Pharmacy staff are the most critical stakeholders in this OIP, and the
success or failure of any change initiative rests on their buy-in and commitment. While patient
safety and satisfaction were an important symptom of the problem of practice, the main causes

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

35

relate to the significant operational changes that impacted pharmacy staff, and how those
changes translated into their daily work. As such, the OIP needs to take into account employee
perceptions at every stage of the change plan, by engaging them and soliciting their feedback on
a regular basis. The organization’s leadership team also represents a significant internal force
that will shape the OIP. As outlined earlier, one of the opportunities that this OIP presents is the
ability to affect change in the prevalent forms of leadership that are currently exercised. The
leadership team will also play a critical role in communicating both internally and externally and
will be central in every aspect of the change plan (Cawsey et al., 1996; Goodman & Truss, 2004;
Kotter, 2012). Finally, the role of internal resources in the organization cannot be overlooked or
underestimated. The functioning of the pharmacy is dependent on human, physical, and financial
resources, and it is therefore expected that resources will play both an enabling and constraining
role in the OIP, which will be mediated by the leadership team who have control over resourcerelated decisions. When considering all of the above factors, and as will be evidenced by the
detailed organizational analysis in chapter two, the organization is not only ready for change, but
given the implications of the problem of practice, change is urgently needed.
Chapter Summary
This chapter introduced the problem of practice and contextualized it within the historical
and organizational factors that underpin this OIP. The chapter also identified the prevalent forms
of leadership within the organization and highlighted the current gaps that the OIP seeks to
address. By reviewing and summarizing the relevant literature and framing the problem of
practice using Bolman and Deal’s (2013) structural frame, I was able to identify the main
considerations that influence and shape the problem of practice. These factors form the
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foundation of the vision for change that was also introduced, and which will be explored in depth
in chapter two.
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Chapter 2: Planning and Development
Chapter one of the OIP provided the contextual and theoretical background, framing the
problem of practice. In this chapter, the emphasis moves from describing the need for change to
establishing the foundations for planning change. This is done by exploring the role of leadership
in organizational change and how it can inform and guide the change process. An in-depth
review and examination of Kotter’s (2012) framework for organizational change, followed by a
critical organizational analysis using Nadler and Tushman’s (1980) Congruence Model highlight
the OIP’s approach to change and puts into focus the areas of the organization that are in need of
improvement. I then proceed to consider several possible solutions that can be pursued to address
the problem of practice by weighing their strengths and limitations. The chapter concludes by
examining the ethical dimensions as they relate to organizational change and the specific context
of this OIP.
Leadership Approach to Change
To successfully address the problem of practice, any proposed solution or initiative for
change must be borne out of and reinforced by leadership that is aligned with both organizational
and individual leadership. As introduced in chapter one, the two most prevalent forms of
leadership in the organization are transactional leadership and LMX. Given the nature of the
tasks that are performed in the pharmacy, moving away entirely from transactional leadership,
especially for daily operations, would be problematic if not impossible. My personal leadership
style, however, is anchored around the strong belief in empowering others and being supportive
and authentic in my interactions with employees (Nasra, 2018a). The gap that currently exists
between my individual leadership style and organizational leadership represents an important
opportunity that can be leveraged during the change process. To that end, this section will
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emphasize how elements of transactional leadership essential to organizational functioning can
be combined with relational leadership behaviours (Bauer & Erdogan, 2015) can be harnessed to
promote organizational change.
Transactional Leadership
Transactional leadership, at a rudimentary level and as the theory’s name suggests,
involves the use of rewards in order to achieve results and is based on the principles of exchange
and reciprocity (Burns, 1978). “Transactional leadership occurs when one person takes the
initiative in making contact with others, for the purpose of an exchange of valued things” (Burns,
1978, p. 19). This form of leadership is based on setting objectives, clear rules and regulations,
and establishing formal lines of authority. Transactional leadership, as it is conceptualized today,
is often viewed as part of a “full-range” model of leadership (Bass, 1985) that also includes
laissez-faire and transformational leadership (Antonakis & House, 2014; Avolio & Bass, 2002;
Bass, Avolio, Jung, & Berson, 2003; Jensen et al., 2019; Judge & Piccolo, 2004). Transactional
leadership, as conceptualized in theory, comprises three components: contingent reward,
management by exception-active, and management by exception-passive (Avolio & Bass, 2002;
Jensen et al., 2019; Judge & Piccolo, 2004). Contingent reward is “the degree to which the leader
sets up constructive transactions or exchanges with followers: the leader clarifies expectations
and establishes the rewards for meeting these expectations” (Judge & Piccolo, 2004, p. 755).
Management by exception involves leader intervention, and the difference between its passive
and active forms has to do with when the intervention occurs (Howell & Avolio, 1993). In active
management by exception “leaders monitor follower behavior, anticipate problems, and take
corrective actions before the behavior creates serious difficulties” whereas passive leaders wait
until the behavior has become problematic before taking action (Judge & Piccolo, 2004, p. 756).
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In the context of my organization, standards, rules, and procedures abound and are
essential to the daily functioning of the pharmacies. They are set by governing regulatory bodies
(e.g., OCP), ParentCorp, and internally. Given the highly regulated nature of the business, and
the serious ramifications of errors, collectively, these “tools” are put in place to ensure patient
safety. In order to proactively reduce errors, workflows and SOPs are incorporated within the
information technology (IT) system used in the pharmacy and are actively monitored by the
pharmacist on shift. The pharmacist also interjects as needed to address any workflow issues
(e.g., backlogs, delays). Despite these controls, errors do occur, and in these situations, it is the
leader’s responsibility to remedy the mistakes, and to log and report them accordingly. All the
above represent traditional examples of both active and passive management by exception
(Howell & Avolio, 1993). Moreover, both pharmacist and support staff receive annual financial
incentives that are contingent on performance metrics which are set at the beginning of each
fiscal year, such as customer satisfaction ratings and the number of medical reviews and clinical
services performed (ParentCorp, 2018c). Any proposed solutions to the problem of practice will
need to maintain these transactional leadership elements given that they are fundamental to the
operation of the organization. The highly transactional nature of the work, however, does not
imply that leader-follower exchanges and relations cannot be improved and enriched through the
change initiative, which will be explored next.
Relational Leadership – LMX
LMX theory is founded on the premise that leaders’ interactions with followers are
differentiated (Day & Miscenko, 2015; Erdogan & Bauer, 2014; Graen & Uhl-Bien, 1995;
Scandura & Graen, 1984). Prior to the introduction of LMX’s precursor, vertical dyad linkage
(VDL) theory in 1975, the prevailing leadership models assumed that leaders interacted with
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their followers in a uniform manner and had homogeneous perceptions, behaviours and reactions
(Dansereau, Graen, & Haga, 1975; Graen & Uhl-Bien, 1995). VDL theory challenged that view
and posited that leader behaviors progress and change through interacting with followers and that
these interactions were not uniform, but unique to each leader-follower dyad (Dansereau et al.,
1975). LMX theory built on this concept of relationship differentiation and viewed that the
quality of the relationship between leaders and followers was central to understanding leader
effects on followers, teams, and organizational outcomes (Bauer & Erdogan, 2015; Day &
Miscenko, 2015).
According to LMX theory, leader-follower interactions span a continuum that ranges
from basic “economic exchange” interactions that do not go beyond job-descriptions (lowquality) to “social exchange” relationships characterized by trust and respect (high-quality)
(Erdogan & Bauer, 2014; Graen & Uhl-Bien, 1995; Pellegrini, 2015). “Economic exchange”
interactions have also been described as transactional in the literature (Bauer & Erdogan, 2015;
Day & Miscenko, 2015; Erdogan & Bauer, 2014). It is important to note that while there are
overlaps with transactional leadership, economic exchange or transactional exchanges in LMX
theory are referred to as such to imply a lack of social investment on the part of the leader and
the follower in the relationship, and that these interactions rarely go beyond what job
descriptions dictate (Pellegrini, 2015). Whereas transactional leadership theory is concerned with
leader behaviours, LMX theory focuses on the quality and the nature of the relational exchanges
and dynamics between the leader and follower. Given the above, even a high performing
employee according to transactional leadership theory, could be described as having low-quality
exchanges according to LMX theory. This is pertinent to the OIP because as mentioned earlier,
transactional processes are “built into” organizational operations. By focusing on the quality of
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the exchanges that employees and leaders have, the OIP can leverage LMX theory to address
some of the concerns outlined in the problem of practice. In adopting this approach, I am also
able to emphasize those aspects of my leadership style that are relational in nature and that focus
on employee empowerment and engagement, as described in my leadership position statement in
chapter one.
Over the last decade, LMX scholars have turned their attention to exploring what factors
can enhance leader-follower relationship quality (Martin, Guillaume, Thomas, Lee & Epitropaki,
2016). Several studies have found that leader delegation can build trust and is related to higher
LMX quality (Bauer & Erdogan, 2014; Bauer & Green, 1996; Yukl, O’Donnell, & Taber, 2009).
This is highly relevant to my OIP as task delegation between pharmacists and PTs has been
identified as an area that needs to be addressed given that pharmacists are not delegating tasks
properly. Other factors that can improve LMX relationship quality include: showing empathy
towards followers (e.g., Mahsud, Yukl, & Prussia, 2010); expending effort in building the
relationship (e.g., Maslyn & Uhl-Bien, 2001); increasing perceived fairness in interacting with
followers (e.g., Erdogan, Liden, & Kraimer, 2006; Masterson, Lewis, Goldman, & Taylor,
2000); and behaving ethically (e.g., Mahsud et al., 2010; Walumbwa, Cropanzano, & Goldman,
2011). All these factors are highly pertinent to my organizational context and OIP.
As highlighted earlier, transactional leadership elements are built into the organization’s
operations. They are imposed through regulatory bodies as mechanisms to ensure patient safety
and compliance with regulations. Accordingly, and regardless of personal leadership style,
leaders in the organization, due to structural elements of the operational environment (Bolman &
Deal, 2013), must engage in transactional exchanges with followers as part of their regular tasks.
In fact, pharmacists themselves who are the de-facto leaders during each shift, are also subject to
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the same constraints that govern their work. Put differently, the operational environment, through
its regulation, standards, rules, procedures and workflows, structures how leaders and followers
interact and perform their jobs. On the other hand, the interpersonal dyadic exchanges that take
place during and outside of work shifts, are influenced and shaped by relational variables such as
trust, fairness, engagement and cooperation that are rooted in social exchange (Blau, 1964).
Social exchange theory dictates that when leaders behave in supportive ways that are beneficial
to followers, it motivates employees to behave in a reciprocal manner that is beneficial to the
leader (Martin et al., 2016). Through reciprocal mutually beneficial interactions, leaders and
followers improve the quality of their exchanges, at times going above and beyond what is
expected of them (Erdogan & Bauer, 2014; Erdogan, Sparrowe, Liden, & Dunegan, 2004; Graen,
Novak, & Sommerkamp, 1982). Figure 1 below depicts how both transactional leadership and
relational behaviours (derived from LMX) manifest themselves in my organization and can be
leveraged in the OIP.
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By engaging in both transactional and interpersonal leadership interactions with
followers, leaders in the organization display a hybrid Structured Relational Leadership style
that incorporates elements of both leadership theories. As can be noted in Figure 1, those aspects
of SRL that correspond to transactional leadership can be categorized as “managing” behaviours,
while elements of SRL concerned with interpersonal aspects of LMX can be described as
“engaging” behaviours. Both classes of behaviours are essential to the OIP given that the
problem of practice requires paying attention to the processes and mechanisms (i.e., structures)
that govern tasks to avoid errors and maximize efficiency, as well as ensuring that employees are
motivated and satisfied. Moreover, elements of my personal leadership style are also featured in
the social exchange end of the LMX continuum, and as will be described in later sections of this
chapter and in chapter three, communication and building trust are fundamental to the
implementation of the change plan, especially since employee morale and engagement are key
considerations for my OIP.
Framework for Leading the Change Process
The Change Management literature offers several models and frameworks that could be
leveraged to implement change in organizations; each with its own strengths and limitations.
Selecting the appropriate framework to use should be guided in part by the model’s ability to
provide the appropriate level of insight into the OIP. In my organizational context, the changes in
pharmacy practice that have precipitated some of the negative outcomes observed are best
described as radical change. This type of change, which can also be described as a paradigm
shift, involves major transformations in how things are done within an organization (Armenakis
& Bedeian, 1999; By, 2005; Greenwood & Hinings, 1999). Other key considerations I weighed
when evaluating change models was their ability to handle change that is complex and
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multifaceted. Given the above, my review of the literature determined that Kotter’s (2012)
change model resonates with the current reality of my organization, where a sense of urgency has
already been established due to the nature of the operational changes that are unfolding, as well
as the seriousness of some of the outcomes (i.e., impact on patient health) (Kotter & Cohen,
2002; Nasra, 2018a). Determining how change must be implemented in the organization is
equally important to recognizing that change is needed in the first place (Kotter & Schlesinger,
2008) and Kotter’s (2012) model represents a phase-driven strategic approach that highlights
structural and procedural change both of which are critical to the OIP. More specifically, the
framework operationalizes the change process and provides a road map that can be followed for
implementing change (Pollack & Pollack, 2015).
Kotter’s Change Framework
Kotter’s change framework proposes eight distinct steps or phases that are required to
achieve successful long-term change within the organization (Kotter, 2012; Kotter & Cohen,
2002). These eight steps were identified to counter the eight common errors that leaders commit
that undermine any change initiative or transformation process (Kotter, 2007, 2012). Below, I
describe in detail Kotter’s (2012) logical eight-step model and its application to my OIP.
Establishing a sense of urgency. The first step in Kotter’s (2012) framework is
concerned with highlighting the pressing need for change in the organization. Like Cawsey et
al.’s (2016) “awakening” phase, this step is critical because it motivates stakeholders by
emphasizing the gaps between the current and desired organizational states, and the impact that
inaction will have on the organization. In my context, the radical changes that have reshaped the
field of pharmacy practice on their own represent a pressing need for organizational change
(Lynas, 2011; OCP, 2012). When considering the additional symptoms of increased errors and
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the risk they pose to patient safety, lowered employee job satisfaction, and higher number of
patient complaints (Organization X, 2016b, 2017b), the need for change and remediation to
correct these concerns becomes all the more pressing and urgent. As such, both management and
employees are already aware of the urgent need for change, however, further urgency could be
emphasized by senior leadership through communication leading up to the implementation of the
change plan, which will be detailed in chapter three, as well as during the annual employee
performance reviews and the posting of pharmacy performance metrics and highlighting the
increasing error rates and lowered patient satisfaction ratings.
Creating a guiding coalition. For a change initiative to be successful it is critical to have
champions who act as change drivers within the organization (Cawsey et al., 2016). Leaders on
their own cannot affect permanent change (Kotter, 2012). Change drivers need to be
organizational members who have proven leadership expertise, are credible and trusted, and
possess position power (Calegari et al., 2015; Kotter, 2012). I also believe that for change to be
effective, employees should feel that their voices are heard, and having employee representation
in the guiding team will facilitate communication and enable trust (Calegari et al., 2015; Hoadly
& Lamos, 2012). Accordingly, in my organization, the change implementation plan will involve
the creation of guiding leadership teams that would consist of myself, the other partner and Chief
Pharmacist, as well as representatives from the pharmacist and support staff cadres. Involving
employees at this early stage ensures that they act as change agents (Cawsey et al., 2016) who
help facilitate buy-in and create a sense of engagement and ownership over the change initiative.
As will be detailed in chapter three, the guiding teams will play a critical role in all aspects of
planning and implementing the change plan as well as a central role in the communications plan.
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The implementation plan will also include key stakeholder consultations at various stages, which
will further enable employee engagement and participation in the change initiative.
Developing a vision and strategy. With the guiding coalition taking on a leadership role,
it is essential to develop a clear succinct vision of where the organization needs to be (i.e., future
desired state) (Kotter, 2012). Simply highlighting the need for change and emphasizing its
urgency is not enough. Effective leadership entails creating a vision and strategy for
organizational change that can serve as a compass that guides the organization through
challenges and unpredictability (Leavy, 2012). A clear vision and strategy generate a sense of
purpose, commitment and direction (Kotter, 2012). As will be elaborated in chapter three, the
vision and strategy for change will be developed by senior leadership along with employee
representatives who together will form the guiding teams. Moreover, putting forth an achievable
vision that is agreed upon by various stakeholders and that embodies the organization’s values
and goals helps create a shared organizational understanding of the overall change initiative and
can galvanize all stakeholders in support of those goals. Accordingly, and as will be outlined in
the communications plan, employee consultation will take place on a regular basis, with the
guiding team seeking employee input at various stages in the implementation plan. Patients as
key stakeholders will also be heard as their feedback on the effectiveness of the change plan is
also an integral part of the evaluation and the monitoring components of the OIP, as will be
discussed in chapter three.
Communicating the change vision. Successful leaders can articulate and communicate
the vision for change clearly throughout the organization, and in the process generate buy-in and
motivate employees to contribute to the change initiative (Kotter, 2012; Leavy, 2012). Chapter
three will provide at a granular level the communication strategy that will be employed during
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the implementation of the change plan. Having open communication channels and
communicating regularly and extensively enables the change drivers to maintain the same level
of urgency throughout the change effort (Klein, 1996). Communication also allows the guiding
team to provide updates as they monitor progress, raise awareness, and ensure continued
employee engagement which is critical for engagement and can further enhance employee
commitment to the change effort (Kotter, 2012; Reissner, Pagan, & Smith, 2011). During the
implementation stage, it is therefore essential for the guiding teams to promote trust and
openness, and by communicating the change vision effectively, employees begin to feel that they
are directly involved in the change effort which can further enhance their readiness for change
(Cameron & Green, 2004; Jimmieson, Peach, & White, 2008; Kotter, 2012). The communication
plan that I developed emphasizes that all organizational members should be familiar with the
change vision and strategy and that messaging should be reinforced repeatedly, especially by the
pharmacist and support staff representatives of the guiding teams (Appelbaum, Habashy, Malo,
& Shafiq, 2012; Armenakis & Harris, 2002; Kotter 2012).
Empowering employees for broad based action. Kotter’s fifth step is all about enabling
action and removing obstacles (Kotter, 2007). In addition to being change agents, the guiding
coalition teams need to facilitate the change effort by monitoring progress and identifying the
core challenges that may arise throughout implementation and putting forth concrete plans to
resolve them. As such, a robust monitoring and evaluation plan was specifically designed for this
purpose and will be described in detail in chapter three. Moreover, empowering employees
involves getting rid of existing systems or barriers that undermine the change vision (Kotter,
2007, 2012). As such, as will be noted in the critical organizational analysis in the following
section, I paid special attention to the structural elements of the organization (e.g., SOPs,
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workflows) that have contributed to low employee morale and ensured that those elements were
addressed in the proposed solutions. Empowering employees is also critical in the
implementation of the change plan, as such, senior leadership in the organization (i.e., myself
and the Chief Pharmacist) need to ensure that any required resources are made available, for
example by providing necessary resources and incorporating the change plan costs into the
organization’s budget. By empowering the guiding teams, organizational leaders would not only
be facilitating the implementation of the change strategy, but they also give employees a sense of
control and ownership which can only enhance their support and buy-in and improve their
adaptability to change (Jimmieson et al., 2008; Kotter, 2012).
Generating short term wins. Kotter (2007, 2012) highlights the importance of dividing
the change process into distinct phases in order to plan for visible improvements and create short
term wins. By monitoring and evaluating progress, the leadership team can adapt plans based on
the level of progress that is being achieved (Kotter, 2012; Mento, Jones, & Dirndorfer, 2002). As
such, highlighting progress and key milestones feature greatly in the implementation plan, as
well as in the monitoring and evaluation strategy described in chapter three. At a high level,
throughout the change initiative, this would involve the guiding teams reviewing periodic
performance metrics, customer survey data, and employee satisfaction indices and sharing any
improvements with employees on a regular basis. In addition to adapting plans and making the
required course corrections, this phase in Kotter’s framework enables the guiding team to
recognize and celebrate achievements, which further empowers and motivates employees and
improves engagement, thereby sustaining the change effort (Kotter, 2012).
Consolidating gains and producing more change. Kotter (2007) cautions leaders about
“declaring victory too soon” during the change initiative. Instead, during this seventh step, it is
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critical that leaders develop the appropriate systems, processes and procedures in support of the
change vision. Using the credibility generated by the short-term wins, the guiding coalition
should assess the progress that has been made, as operationalized in the monitoring and
evaluation strategy, and endeavour to change all the systems and structures that are no longer
aligned with the new vision. Other changes that should be implemented during this stage include
developing, promoting, or hiring organizational members who can further implement the change
plan and reinvigorate the change process (Kotter, 2007, 2012). These actions are required
because oftentimes, employees who are resistant to change may not publicly oppose it during the
early stages, and instead wait for the right opportunity and time to hinder progress, a point I will
revisit in chapter three (Kotter, 2012). Moreover, given that the change initiative would have
been ongoing for some time, it is easier for employees at this stage to become complacent and
fall back into the old way of doing things (Kotter, 1998, 2012). As such, the guiding team and
leaders need to expend additional effort and resources in order to maintain momentum and see
through the transformation process. As progress is achieved, employees’, and sometimes
leaders’, sense of urgency may wane as other priorities pop up which can threaten the long-term
success of the overall change project (Kotter, 2012). As such, both the implementation and
communication plans that I developed explicitly address these concerns and attempt to mitigate
them.
Anchoring new approaches. The final stage in Kotter’s (2012) framework is similar to
Cawsey et al.’s (2016) “institutionalization” or Lewin’s “refreezing” steps. Once systems and
procedures have been put in place, it is incumbent upon the leadership team to explicitly
demonstrate how the new “way of doing things” is tied to organizational outcomes. This not only
reinforces change, but also ensures that organizational members understand how the overall
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initiative has contributed to closing the gap between the organization’s initial state and its desired
state. Within my organization, this translates to leaders taking concrete steps to make the new
organizational reality a part of the organization’s operations. This can be achieved in different
ways such as highlighting improved organizational performance (e.g., metrics), and
demonstrating the positive impact that new processes have on employees. A more tacit way in
which my change plan ensures that change is lasting is directly tied to the actual proposed
solutions which involve structural changes in how tasks in the pharmacy are performed
(workflow), and which would be very difficult to reverse. What is critical in this step is that all
organizational members begin to view the new organizational state as “the new reality” and
cease to think of the new processes as being a part of an organizational change initiative. By not
implementing this step, many organizations fail at sustaining the change effort (Kotter, 2007,
2012).
Critical Organizational Analysis
One of Kotter’s (2012) framework’s limitations is that it does not explicitly have an
organizational analysis phase as other change models do (e.g., Cawsey et al.’s, (2016) Change
Path Model; Beckard & Harris’s (1987) Change Management Process). Conducting a critical
analysis that will explore in detail all the factors impacting the organization, and by extension the
problem of practice, is one of the most important elements of an OIP. As such, selecting the
appropriate frameworks and tools to conduct the organizational analysis critical. As described in
chapter one, and by reviewing the findings of the PEST analysis (see Table 1), it becomes
evident that both external and internal factors have precipitated the symptoms of the problem of
practice and current organizational state. As such, it is imperative to study the organization
utilizing a holistic systems-based perspective. Nadler and Tushman (1980) describe this
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diagnostic stage as the “collection, integration, and analysis of data about the organization and its
environment” (p. 197). Nadler and Tushman’s (1980) Congruence Model is rooted in systems
theory (Katz & Kahn, 1978; von Bertalanffy, 1950) and examines the organization’s context, its
transformational processes and outputs, and as such was selected as the framework for this OIP’s
organizational analysis.
The Congruence Model
Open systems theory examines the interactions and outcomes of the various components
that comprise a particular system (von Bertalanffy, 1950). Katz and Kahn (1978), in their
seminal work The Social Psychology of Organizations further elaborated by describing open
systems as being comprised of one or more “cycles” that take in inputs, transforms them, and
produces outputs. The authors suggested that by considering organizations as open systems,
scholars would be able to gain a better understanding of the way that people behave and interact
in organizations (Katz & Kahn, 1978). Such a view of organizations, while extremely
enlightening, required further elaboration to better understand how organizations as open
systems functioned (Kast & Rosenzweig, 1972). Nadler and Tushman’s (1980) Congruence
Model provides a detailed and specific framework that allows for understanding the organization
at multiple levels of analysis by examining sub-systems within the organization. Moreover, the
Congruence Model posits that for organizations to be effective, they must constantly evolve
through management and restructuring (Nadler & Tushman, 1980). The presence of misaligned
processes and structures within the organization leads to inefficiencies and undesirable
outcomes. This is where the concepts of “fit” and alignment between the various units and
processes of the organizational system become key (Nadler & Tushman, 1980). Organizations
whose sub-systems (i.e., units) are congruent and fit well together function in an optimal way.
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By extension, the presence of incongruence leads to problems in organizational functioning
(Nadler & Tushman, 1980). Figure 2 below summarizes the organizational analysis that I
conducted using the Congruence Model.
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Figure 2. High level application of organizational congruence model. Adapted from Nadler, D. A., & Tushman, M. L. (1980). A model
for diagnosing organizational behavior. Organizational Dynamics, 9(2), 35-51.
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According to the Congruence Model, organizations are comprised of the following
components: tasks, individuals, and both formal and informal organizational structures (Nadler
& Tushman, 1980). While Figure 2 allows for a high, systems-level view of the organization, the
details relating to each component, as well as the analysis of the fit between the different
elements are provided below.
Inputs. There are multiple factors that impact the organization which require careful
consideration. The PEST analysis conducted in chapter one (see Table 1) reveals that the
expansion of the scope of practice for pharmacists through Bill 179 and the regulation of the PT
role represent significant political shifts that have had considerable impact on the tasks of
employees and the overall functions of the pharmacy (OCP, 2012; OPA, 2014). Another political
tension centres around the need to balance the organization’s revenue-generating activities (i.e.,
for-profit orientation) and the imperative to provide an essential public service without
restrictions (Nasra, 2018a, 2018b). This is directly tied to the economic forces that shape and
influence the organization’s operations which include a reduction in revenue as a result of the
implementation of Bill 102 which eliminated professional allowances and rebates (Grindord et
al., 2013; Rosenthal et al., 2012; VanderElst, 2010). On the other hand, the provision of clinical
services such as immunizations and conducting medical reviews represent new revenuegenerating activities that also influence the organization. Other economic factors that influence
the organization also fall under the category of resources and are related to the cost of hiring
support staff and budgetary restrictions. In 2018, the average starting wage for PTs was $22.30
while PAs earned $14 (ParentCorp, 2018d). Hiring PTs therefore represents a significant
investment and cost that needs to be weighed carefully. In addition to fiduciary obligations (i.e.,
generating profit), the parent company and the franchisees/parnters, myself and the Chief
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Pharmacist, set annual operational budgets and monitor financial performance metrics on a
regular basis.
There are several social factors that impact the organization which were explored in
depth in chapter one. These included the issue of role overlap between pharmacists and PTs
(Beales & Austin, 2006) and the tensions that arise as a result. The inability of patients to
distinguish between support staff has also been identified as an important issue related to patient
perceptions which contributes to the symptoms of the problem of practice (Nasra, 2018a). The
transactional nature of leader-follower exchanges is another social factor, as is the differential
treatment from pharmacists that PTs and PAs experience, which has been linked to the creation
of in-groups and out-groups (Graen & Uhl-Bien, 1995) and resulted in staff feeling undervalued
as noted in employee surveys (Organization X, 2016b, 2017b).
Additionally, there are several technological factors that need to be examined. For
example, outdated SOPs and workflows do not adequately reflect the new operational reality of
the pharmacies. The IT systems that are currently being used are also important to the daily
functioning of the pharmacy and would be impacted by any workflow changes proposed by the
OIP. It is also essential to consider the fast-paced and task-oriented nature of the work
environment which has contributed to issues related to task delegation on the part of pharmacists,
such as not delegating technical tasks to PTs, or delegating tasks to PAs when they should not be
doing so.
When considering the inputs of a system, one must not overlook the importance of
culture. While my OIP does not explore the role of organization culture in depth, in the context
of this analysis, organizational culture encompasses various elements such as ParentCorp’s
values that the organization is expected to embody and reflect (ParentCorp, 2018b) as well as the
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values that my organization espouses which were elaborated on in chapter one, and which centre
around the strong belief in community engagement and providing equal care and access to
patients from all socio-economic backgrounds (Nasra, 2018a). Another contributor to
organizational culture stems from the profession itself. Pharmacy is an ancient profession with
deep religious and spiritual roots that to this day can be seen in the various symbols that
represent it (e.g., the bowl and serpent-wrapped staff). Priests and men of religion across the
centuries concocted remedies from plants, natural minerals and animal products to heal ailments
(Kremers & Sonnedecker, 1986). Today, more and more practitioners are recognizing that the
future of pharmacy lies not in the disease-centered model that was promoted by the scientific
revolution, but in a patient-centric approach that treats body, mind and spirit (de Oliveira &
Shoemaker, 2006), which is in-line with my organization’s values and my personal beliefs as a
leader. Although culture is not explicitly addressed in my OIP, its influence permeates all its
aspects, from the actual problem of practice which seeks to address ethical concerns impacting
patient safety to the leadership approach that emphasizes the relational aspects of leader-follower
interactions.
Strategy. The organization’s strategy, simply stated, centres around serving community
healthcare needs in a safe and effective manner, while also generating profit and fulfilling
responsibilities to shareholders and ParentCorp. Given the problem of practice, there currently
exist gaps in performance that prevent the espoused strategy from being implemented effectively
which is symptomatic of an incongruence between one or more components of the organization’s
transformational process and/or its inputs (Nadler & Tushman, 1980; Seong, Kim, & Szulanski,
2015). A gap between the way an organization operates (i.e., theories-in-use) and the way it
claims to operate (i.e., espoused theories) is highly problematic and should be addressed (Argyris
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& Schön, 1974; Beer & Nohria, 2000). In chapter one, the current organizational gaps that I
highlighted revolved around the organization’s performance, specifically as it pertains to
increasing dispensing error rates and declining employee engagement and patient satisfaction.
The OIP’s proposed solutions and implementation plan, which will be discussed in detail in later
sections of this chapter and in chapter three are geared towards addressing these gaps and
moving the organization towards its desired optimal state (Bolman & Deal, 2013; Cawsey et al.,
2016).
Formal organization. The formal organization according to the Congruence Model
includes “the range of structures, processes, methods, procedures and so forth that are explicitly
and formally developed to get individuals to perform tasks consistent with organizational
strategy” (Nadler & Tushman, 1980, p. 44). In my context, these include a variety of systems and
tools that are used to manage tasks and ensure compliance such as SOPs, regulations, and
standards set by governing bodies (e.g., OCP), IT systems and procedures managed by
ParentCorp, as well as the workflows that are adapted to all of the abovementioned “controls”
and designed to facilitate task performance efficiently. Error reporting mechanisms are also part
of the formal organizational arrangements but are considered to be external to the system and
therefore will not be explicitly addressed in this analysis or the OIP.
Informal organization. According to Tushman and Nadler (1992), the informal
organization develops over time and encompass “the structures and procedures that emerge while
the organization is operating” (p. 51). These arrangements are typically “implicit and unwritten,
but they influence a good deal of behavior” (Nadler & Tushman, 1980, p. 44). In my OIP’s
context, the informal organization would include the routines that developed over time between
pharmacists and support staff as they worked together. The deviation of these informal

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

58

arrangements from formal organizational structures represents serious concerns that contribute to
the problem of practice such as the delegation of tasks to PAs out of convenience, or not utilizing
PTs technical expertise in order to avoid disruption of pharmacists’ work habits (Nasra, 2018a).
People. While the organization employs a wide-range of employees to manage frontstore operations, for the purposes of the OIP, only individuals involved in pharmacy operations
will be included in the analysis. The most senior individual is the Chief Pharmacist who is also a
co-owner/partner in the organization. The Chief Pharmacist is the individual who directly
interacts with governing bodies and insurance companies over contractual matters and reporting
requirements. The organization also employs pharmacists, and PTs and PAs as support staff. As
detailed in chapter one, each shift includes a pharmacist who is paired with one or more support
staff members (PT or PA). The pharmacist on-shift is the de-facto leader, and all aspects of
pharmacy operational decisions rest with him/her, with the Chief Pharmacist only contacted in
exceptional circumstances that require intervention or additional assistance. When dispensing
errors occur, it is the pharmacist who signed off on the prescription in question that is involved in
reporting the incident to the OCP. The Chief Pharmacist, however, is advised and involved in the
review process. The pharmacy team also engages with the CHRO (myself) who is responsible
for recruitment, training design, performance reviews, and workflow design and optimization.
All these tasks are carried out in conjunction with the Chief Pharmacist. Beyond the
identification of the different roles in the pharmacy, Tushman and Nadler (1992) emphasized the
importance of “identifying the characteristics of the employees or members … individual
knowledge and skills, the different needs or preferences of individuals, and the perceptions or
expectations that they develop” (p. 49). These issues will be considered in more detail in chapter
three, as they are fundamental to the successful implementation of the change plan.

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

59

Work/Task. The main functions of the pharmacy are the dispensing of prescribed
medications and the delivery of clinical services within the scope of practice (Abramowitz, 2009;
Remington, 2006). Chapter one described at a high-level the tasks that comprise these two
functions and who is allowed to carry them out as per OCP regulations and internal policies.
Table 3 below provides a detailed break-down of the tasks that comprise a pharmacy’s workflow
and the pharmacy member who is permitted to perform them.
Table 3
Pharmacy Workflow Tasks
Task
Description
(Staff member
who can perform
task)
Data Entry
Task involves receiving prescription from patient, entering the details in the
(Any pharmacy
IT system, and placing the prescription in the filling queue based on agreedteam member)
upon delivery time. This step also includes confirming whether there are any
changes to the patient profile and making those changes accordingly. Once
the data is entered in the system, it is automatically adjudicated (sent to
appropriate insurer to verify coverage and costs) and authorized.
Filling
(Any pharmacy
team member)

Task involves retrieving prescription bottles from shelf (or materials for
pharmacist to prepare a product such as creams etc.), measuring the required
quantity (e.g., counting), placing the drugs in appropriate packaging (e.g.,
vial), printing the labels utilizing the IT system, and placing the hardcopy of
the prescription, medication bottles used for filling, and vials along with all
the paperwork together in the pharmacist checking queue.

Checking
(Only pharmacist)

Prescription checking is made up of 3 subtasks, Data Verification (DV),
Clinical Verification (CV), and Product Check (PC).
DV

Data verification involves confirming that the information entered
in the IT system matches the prescription (i.e., the technical
aspects of the prescription).

CV

Clinical verification involves reviewing the clinical
appropriateness of a prescription (e.g., drug interactions) by
referring to patient profile in IT system.
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Table 3 (continued).
PC

Product checking confirms that a prescription has been filled
correctly (by comparing bottles used for filling against
prescription and verifying the contents of vial). This step also
confirms that the labels on the vials match the items that have
been dispensed and prints the receipts before bagging the items.

Pick Up
(Any pharmacy
team member)

This task involves looking up the patient profile and determining the status of
their prescription at the designated pick up area. Prescriptions are then
reconciled in the IT system (i.e. scanned to denote delivery) and provided to
the patient. If any notes have been included with the prescription, they are
provided to the patient. If patient counseling is required, the prescription is
moved to the counseling area where is it delivered after counseling has taken
place.

Counseling
(Only pharmacist)

This task involves providing the patient with any information regarding the
prescription that is being picked up and answering any questions the patient
may have. If follow-up is necessary, the request is logged in the IT system.

Note. Adapted from ParentCorp Playbook: Roles & Responsibilities.

As can be noted from the table, all the tasks can be completed by the pharmacist, which
by design creates substantial role overlap. This is in part due to the fact that the pharmacist
should be able to independently operate the pharmacy in the absence of support staff. There is
also significant overlap between PT and PA tasks. It is important to note that this division is a
representation of what is legally allowed per legislative and policy guidance. Workflows in the
pharmacy can be designed in a way that limits the tasks that each member undertakes even if
their scope permits them in order to maximize efficiency and optimize performance. A challenge
for this OIP is therefore to delineate the various tasks that each team member can perform and
attempt to reorganize them in a manner that addresses the concerns that were raised in the
problem of practice. This will be addressed in detail in the proposed solutions section that
follows.
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Outputs. Tushman and Nadler (1992) highlight that in systems and organizations “the
critical question is not what are the components, but what is the nature of their interaction and
how do the relationships among the components affect how they combine to produce output” (p.
51). Viewed from this a macro/system level perspective, the pharmacies’ outputs at a
foundational level are the delivery of healthcare products and services and the revenue that is
generated from operations. At the meso/unit level, the outputs of the system revolve around the
functioning of the pharmacy teams. This would include each shift (team) working efficiently and
effectively to fill prescriptions and dispense clinical services to patients on time and without
incident. An important output that is related to the team’s tasks is ensuring that each shift clears
all the prescription queues on time to prevent handing over a backlog to the following shift, as
this would be one area where the output directly impacts the performance of tasks (feedback). At
the micro/individual level, the system’s outputs can be summarized into two broad categories,
employee engagement and satisfaction and patient satisfaction.
Fit Analysis
Analysing the different components of the organization reveals important tensions and
areas where there is a lack of fit/congruence. First, the outdated SOPs and workflows have a
direct negative impact on the performance of tasks for all the employees. This represents a key
area that needs to be addressed by the OIP’s proposed solutions. Second, the routines and work
habits that have developed over time (informal organization) also do not align properly with the
tasks. When pharmacists delegate technical tasks to PAs, this poses a high risk to patient safety,
in addition to being in direct contradiction with OCP regulations (formal organization). Failing to
properly make use of PTs’ skills also has detrimental impacts that range from suboptimal
pharmacy performance to low employee engagement and morale. As such, the proposed
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solutions which will be explored in the following section will focus on these areas where there is
a lack of fit between the organization’s formal and informal processes and employee tasks, as
they prevent the organization from successfully pursuing its goals and strategy (Nadler &
Tushman, 1980).
While the Congruence Model analysis has provided crucial insights, there is an additional
component that is critical to the problem of practice that has not been tackled that relates to
patient perceptions of pharmacy support staff, which was discussed in chapter one. While patient
satisfaction is an important output of the system, customer satisfaction surveys have revealed a
over the last two years, PAs received 32% more complaints than PTs, often noting a lack of
willingness to help or assist with patient queries (Organization X, 2016b, 2017b). The surveys
also reveal that one of the main reasons behind this discrepancy is the inability of patients to
differentiate between various members of the support staff, and an expectation that they are all
equally knowledgeable. This issue impacts both patient and employee satisfaction levels and is
therefore pertinent to this OIP.
The areas of concern and incongruence (lack of fit) that were uncovered and underscored
by the critical organizational analysis are at the foundation of the problem of practice, and by
extension represent the main focus that the proposed OIP solutions should attempt to address in
the following section.
Possible Solutions to Address the Problem of Practice
The critical organizational analysis shed light on key areas of misalignment within the
organization, which when coupled with the contextual background and priorities for change
discussed in chapter one, can inform several possible solutions for the problem of practice.
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Accordingly, three mains solutions are being advanced in this section that tackle the following
focuses stemming from the analysis:
-

Suboptimal performance and safety concerns related to outdated workflows. This focus is
directly related to pharmacy staff's ability to provide products (prescription filling) and
services (clinical services) in a safe manner that complies with regulations and policies.

-

Employee engagement and morale. This topic is tied to the observed decline in employee
engagement and satisfaction surveys (Organization X, 2016b, 2017b).

-

Patient satisfaction and perceptions related to pharmacy support staff. This is linked to
the increased level of complaints lodged against PAs (Organization X, 2016a, 2017a).

Solution One: Modify Pharmacy Hiring Practices/Pharmacy Support Staff Composition
As outlined in chapter one, the symptoms of the problem of practice are linked to the
expansion of the scope of practice for pharmacists and the subsequent introduction of the PT role
(OCP, 2012; OPA, 2014). During each shift, pharmacists and support staff work in close
conjunction in the performance of their tasks (Nasra, 2018a). Given that many of the issues that
are being experienced are related to interactions between pharmacy staff members, one possible
solution that could be implemented is for the organization to employ only PTs or PAs as support
staff. Doing so would eliminate the issue of differential treatment that is currently experienced
by PTs and PAs, and the creation of in-groups and out-groups (Erdogan & Bauer, 2014; Graen &
Uhl-Bien, 1995), which has been linked to lower employee satisfaction and morale (Inoue et al.,
2016).
Hiring PTs. Given that the PT role was introduced to alleviate the increased workload on
pharmacists (Frost & Adams, 2017; Koehler & Brown, 2017; Lynas, 2011), hiring PTs
exclusively may seem like an optimal choice. There is some support in the literature for this
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option. Studies suggest that pharmacists exhibit a more pronounced sense of trust and respect for
PTs than they do PAs (Bullock et al., 2016), and that they view their relationship with PTs as
more collaborative whereas their relationship with PAs is described as more supervisory
(Bullock et al., 2016). Despite valuing PTs more, research findings however also indicate that
pharmacists do not delegate technical tasks to them (Schafheutle et al., 2008), which could be the
result of tensions due to role overlap (Gregory & Austin, 2017; Grindrod et al., 2013) and a
reluctance to give up tasks that have traditionally been associated with their authorities (Pojskic,
MacKeigan, Boon, & Austin, 2014). In other words, dissociating the technical aspects of
prescription filling from the traditional pharmacist workflow has not proven to be simple, as it
can be perceived as a threat to one’s professional identity (Gregory & Austin, 2017). One
important thing to consider however is that an all-PT support staff option means that PTs would
be required to take on all the clerical aspects of pharmacy work previously performed by PAs
(e.g., filing, data entry), which would reduce their ability to assist pharmacists and could have a
negative effect on their engagement and morale (Inoue et al., 2016).
Hiring PAs. The other alternative for this solution would be to exclusively rely on PAs
as support staff. Interestingly, recent studies have found that the majority of pharmacies looking
to hire support staff, tend to hire PAs more disproportionally than PTs (Bullock et al., 2016).
While this option may be appealing given that hiring PAs does create consistency in terms of
who the pharmacist interacts with and can simplify workflows, this does little to alleviate the
increased workload on pharmacists and is therefore not a viable option for the OIP.
Resources. Each pharmacy currently employs four support staff, one PT and three PAs.
The major concern that this option poses relates to cost. In 2018, the starting rate for a PA was
$14, whereas the starting hourly wage for a PT was $22.30, with each full-time support staff
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member works an average of 35 hours a week (ParentCorp, 2018c). Hiring PTs exclusively
would result in an estimated increase of $45,300 annually at a minimum in personnel costs per
pharmacy which is untenable. Hiring decisions in the organization as they relate to costs are
influenced by their impact on profitability metrics that are set and monitored by ParentCorp. One
key performance indicator that ParentCorp sets is the wage-cost-per-script (WCPS). The WCPS
is based on a calculation that considers the average labour costs involved in filling a single
prescription and varies from one pharmacy to another1. The lower the WCPS, the more profitable
the pharmacy is considered (Nasra, 2018a). Switching from a mixed support staff cadre to one
that is exclusively comprised of PTs would significantly increase the WCPS and be considered
detrimental to the financial performance of the organization. Given that there is no legislative
(structural) imperative for a pharmacy to hire PTs, it would be extremely difficult to justify this
solution to shareholders and ParentCorp.
From a senior (and personal) leadership perspective, this solution poses several concerns.
First, and as highlighted above, the increased costs involved in hiring only PTs makes that option
unappealing. Even though I am the CHRO and a partner in the organization, it would be difficult
to justify the costs that would be incurred to the other partner, shareholders and to ParentCorp.
Moreover, having PTs expend time and effort completing clerical tasks that they would need to
take on should they be the only support staff in the organization does not represent an efficient
use of organizational resources, making the financial calculus of this option even less desirable.
Alternatively hiring PAs exclusively does not permit the organization to meet the needs of
patients or pharmacists who will continue to experience strain as they struggle to be solely

1

WCPS is dependent on variables such as pharmacy sales growth, volume of prescriptions and the age of the
pharmacy.
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responsible for both prescription filling and providing clinical services. Viewed from a neoliberal
lens, the option of hiring one type of support staff, whether PA or PT, does not represent a good
way forward for the organization, as it renders it less competitive, less efficient and unable to
effectively regulate its operations in the current environment (Davies, 2014b; Harvey, 2005).
Solution Two: Public Information/Education Initiative
Despite the provision of clinical services in community pharmacies, little research has
been conducted to empirically investigate patient perceptions of these initiatives (Latif,
Boardman, & Pollock, 2013). One aspect of organizational performance that this OIP seeks to
address is patient satisfaction. While operationalized through customer satisfaction survey
ratings, patient engagement has the potential to affect other aspects of the problem of practice,
most notably through the facilitation of the delivery of clinical services. As such, one possible
solution that warrants examination is the implementation of a patient education campaign or
efforts whose aims would be to inform the public as to the different roles of pharmacy team
members as well as the availability and benefits of pharmacy-based clinical services. In addition
to improving pharmacy performance through the increased delivery of clinical services, a key
symptom this intervention seeks to address are patient complaints about support staff inability to
provide healthcare advice (Organization X, 2016a, 2017a).
Pharmacists are in the unique position of being the most accessible healthcare providers
in communities. As such attempts to expand their role in patient education programs has been the
subject of study over the last few decades, as the shift towards patient-centered care continues to
grow (Babb & Babb, 2003; Rupp, DeYoung, & Schondelmeyer, 1992). Studies have
demonstrated the positive impact of pharmacy-based patient education in the management of
diseases such as asthma (McLean, Gillis, & Waller, 2003), cholesterol-level management
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(Tsuyuki et al., 2002; Tsuyuki, Olson, Dubyk, Schindel, & Johnson, 2004), diabetes (Mansell &
Perepelkin, 2011), and cardiovascular disease (Warden, Freels, Furuno, & Mackay, 2014) among
other conditions. Moreover, studies that have explored the impact of education on patient
satisfaction on pharmacy-provided services (e.g., medication management) have reported
positive results (Kim, Martin, Pierce, & Zueger, 2016; McGivney et al., 2007; Naik Panvelkar,
Saini, & Armour, 2009).
Resources. Studies have shown that in order to change public perceptions about the role
of pharmacists’ in communities, appropriate marketing methods are needed (McDonough,
Pithan, Doucette, & Brownlee, 1998). Promoting a product is fundamentally different than
promoting a health service, which requires building the confidence and knowledge of physicians,
patients, and other stakeholders regarding the benefits of such a fundamental change in
community pharmacy practice (McDonough et al., 1998; Perepelkin & Dobson, 2009). As such,
the main resources that are required for this solution would be the development of a tailored
educational and marketing plan that is aimed at providing the public with a clear understanding
of the role of all pharmacy staff. Educating the public as to the role of pharmacists should also
highlight the limitations of what support staff can do, which can go a far way in managing
patient expectations. In addition to improving the delivery of clinical services, this education
campaign can also change patient perceptions and skepticism that pharmacists may be providing
these services to simply improve their bottom-line (Guirguis et al., 2014). The costs of this
solution can vary greatly depending on the type of campaign that is undertaken which can be
limited to pharmacy staff time dedicated to patient education or can include the provision of
educational marketing materials (e.g., printing pamphlets and posters). This solution would
require a comprehensive cost analysis; however, it is fair to expect that the increase in revenue
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generated from the provision of additional clinical services would likely offset a portion of these
costs. Table 4 below outlines for the schedule of payments reimbursed for the delivery of clinical
services.
Table 4
Clinical Services Reimbursement Schedule
Program
MedsCheck – Annual
MedsCheck – Follow-up
• Hospital discharge
• Physician/Nurse referral
• Planned hospital admission
MedsCheck for Long-term Care home residents
MedsCheck at home (if eligible)
MedsCheck for diabetes (if eligible)
Pharmaceutical opinion
Pharmacy smoking cessation program first consultation

Payment
$60
$25 per follow-up

$90 annually
$59 quarterly
$150
$75 annually
$25 follow-up education
$15
$40

Note. Adapted from Ministry of Health and Long-term Care Professional Pharmacy
Services Guidebook 3.0

As can be noted from Table 4, the provision of clinical services effectively and efficiently
can have a considerable financial impact on the organization’s bottom line. One of the current
impediments to capitalizing on this revenue stream stems from the inability of the organization’s
current work processes to effectively free-up pharmacist time so it can be dedicated to the
provision of these services. Viewed from a neoliberal lens, clinical services represent an
untapped market that my organization is currently unable to effectively compete in (Biebricher,
2015; Bloom, 2017). Moreover, from a personal leadership perspective, the benefits of educating
the public as to the roles of various pharmacy team members, as well as the availability of
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clinical services, are extremely appealing given that they can contribute to fewer safety incidents
as well as improved customer satisfaction and employee morale. From a neoliberal perspective,
this solution allows the organization to better compete, by marketing clinical services to patients
via an educational campaign, while at the same time improving pharmacy operations through the
provision of better and safer services. As such, both from a financial and social outcomes
perspective, the costs incurred by implementing this solution would not be difficult to justify to
shareholders as the improvement in patient wellbeing and reduced complaints are important
organizational outcomes.
Solution Three: Redesigning Pharmacy Workflow
Workflow, defined in this OIP as the standardized process for filling prescriptions and
delivering services, is at the core of a pharmacy’s operations and has been identified in the
critical organizational analysis as a significant area of misalignment that needs to be addressed.
Workflow design considers both processes as well as the physical layout and placement of
workstations and other resources in the pharmacy (Angelo & Ferreri, 2005). Inefficiently
designed processes and pharmacy layout have been identified in the literature as being critical
barriers to the provision of patient counseling (Angelo & Ferreri, 2005; Lin et al., 1996) and are
also linked to higher levels of pharmacist dissatisfaction (Lin et al., 2008). Workflow design is
also linked to dispensing error rates (Hoxsie et al., 2006), the ability to integrate new roles in the
pharmacy (Pai, 2005), and pharmacy performance efficiency (Cavaye et al., 2018).
Figure 3 below depicts the current pharmacy workflow, and its steps were described in
detail in Table 3 of the previous section. As identified earlier, the workflow and corresponding
SOPs have not been updated since the expansion of the scope of practice for pharmacists and the
inclusion of PTs in pharmacy teams. Moreover, the current workflow incorporates significant
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role overlap between all pharmacy staff, which has been the cause of tensions, and represents a
structural obstacle contributing to the suboptimization of pharmacy performance (Bolman &
Deal, 2013). As such, one of the possible solutions that this OIP proposes is redesigning the
workflow to address these challenges.

The current workflow for prescription filling is made up of four distinct steps, data entry,
filling, checking and pickup (see Table 3). As can be noted in Figure 3, any pharmacy staff
member can perform the first two steps as well as the final step, whereas pharmacists are the
only professionals who can complete the checking process. The current workflow suffers from
several weaknesses:
-

In its current state, there is no step in the workflow that falls solely within the purview of
a PT’s regulated authority. In other words, the technical aspects of filling the prescription
are not delineated which may have contributed to the observed lack of delegation. The
technical tasks that PTs can perform are data verification and product check which are
currently part of the “checking” process that pharmacists perform (which also includes
clinical verification).

-

The workflow has a high potential for the creation of backlogs or process disruptions.
During the “checking” process, pharmacists conduct three separate sub-tasks, which take
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up a considerable amount of time. If a pharmacist is called upon to counsel a patient or to
deliver a clinical service (e.g., flu shot), the dispensing process cannot move forward,
while additional prescriptions might be entered into the system and filled by support staff.
-

The data verification and clinical verification subtasks, as outlined in Table 3, require
that a pharmacist refer to the IT system to confirm that the technical information that is
entered in the system matches the prescription, and that there are no concerns or
contraindications per the patient profile. Given that the prescription has already been
filled by that stage, any errors that are identified can only be corrected by re-filling the
prescription. Support staff would need to log the mistake, return the drugs to the bottles
when possible, and discard the used vials and labels. Only after the mistake has been
corrected in the IT system, can the filling process start again. In addition to being a timeconsuming process that can result in wasted products (i.e., if they cannot be returned),
errors also trigger an inventory reconciliation process by which the pharmacist and
support staff need to document the error and enter the quantity of drugs that was returned
or discarded.
Designing a new workflow would need to address many of these issues, as well as

attempt to reduce role overlap. From an operational perspective, designing and approving a new
workflow and the costs associated with it are within the purview and scope of authority of senior
leadership (myself and the other partner), and as such, the implementation of this solution is a
viable option for the OIP. Figure 4 below represents (at a high macro level) a possible proposed
new workflow.
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In this new system, the filling process is made up of seven discrete steps. A new task,
prescription intake, is added which allows the pharmacy team to quickly attend to patients,
avoiding line-ups and reducing wait times when prescriptions are dropped off. At this step the
delivery time is agreed upon, which allows the team to better manage the queue by entering the
prescription into the appropriate time slot as opposed to the sequential entry of prescriptions in
the system. The three sub-tasks that comprise the “checking” step (see Table 3) are divided in the
new design, with data verification and clinical verification taking place prior to filling. The
benefits of doing so are two-fold. First data verification can be completely delegated to PTs or
performed by the pharmacist when only a PA is present. By performing these two tasks prior to
the physical filling of the prescription, errors can be caught sooner and addressed, saving time
and resources. The product check step takes place after the filling and is another task that can be
delegated to a PT when present. The specific steps regarding how the new workflow would be
designed will be elaborated on in the implementation plan in chapter three, (e.g., stakeholder
consultations, changes in pharmacy systems, training) but some of the potential benefits of the
new process include role delineation through delegation, error reduction, and increased
efficiency.
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Resources. Redesigning workflows is similar to reengineering or quality improvement
techniques; it needs to be done in a systematic and methodical manner that considers multiple
factors (Aguilar et al., 2013; Nold, 2011). The new workflow needs to identify and remove
barriers to performance, whether they be physical or technological. Hand-offs between tasks
need to be smooth and efficient, waste should be reduced, and redundancies and tasks that have
the potential to create backlogs should be minimized or eliminated where possible (Nold, 2011).
Given that this proposed solution involves process changes in the organization, the change plan
requires an investment of financial resources and time as well as some minor modifications to
the IT infrastructure of the pharmacy which are described below:
-

Time: Based on the timeline required for previous workflow change initiatives in the
organization, it is estimated that the amount of time required for modifying the pharmacy
workflow could take up to 12 months (ParentCorp, 2010).

-

Technology: Since the current IT system already contains modules for the performance of
all the tasks in the proposed workflow, only minor changes in the permissions are
required, to allow PTs to perform the DV and PC steps. In addition, a new computer
terminal dedicated to PTs will need to be installed for each pharmacy, at an average cost
of $6,000 per terminal (ParentCorp, 2018d).

-

Training: The most critical aspect of rolling out a new workflow is personnel training.
This involves both time and financial investment (e.g., for the development of training
materials, job aids, conducting on-the-job training). The detailed cost and description of
the training will be explored in depth in chapter three.
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Weighing the Options of the Three Possible Solutions
Each of the proposed options could represent a path forward for the organization, as does
maintaining the status quo, which can be considered a fourth option. Table 5 below evaluates
each of the possible solutions against its ability to address the three factors identified earlier as
being essential to this OIP. As noted earlier, modifying hiring practices is not only financially
untenable, it only has the potential of addressing safety concerns if only PTs are hired. This
option fails to account for the two other main factors fundamental to the problem of practice.
Given the critical nature of the safety concerns of the problem of practice, maintaining the status
quo is also not a viable option. Combining solutions two and three, however has the potential for
laying down a comprehensive plan that can effectively address the main factors influencing the
OIP.
Table 5
Comparison of Proposed Solutions

Does this solution
address
performance and
safety concerns?
Does this solution
address employee
engagement and
morale?
Does this solution
address patient
satisfaction and
support staff
perceptions?

Solution 1: Modify
hiring practices/support
staff composition

Solution 2: Public
Information/ Education
campaign

Solution 3:
Redesigning
pharmacy
workflow

Solution 4:
Maintain status
quo

Potentially

No

Yes

No

No

No

Yes

No

No

Yes

No

No
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In addition to addressing the major concerns of the problem of practice, both solutions
two and three would allow my organization to better meet its obligations to both its shareholders
and its patients. Educating the public and informing them as to the different roles of pharmacy
team members and the services available to them and redesigning the pharmacy workflow will
allow my organization to achieve its strategy of providing healthcare safely while remaining
competitive (Nadler & Tushman, 1980). Adopting only one of the two solutions could lead to
unintended consequences that might further exacerbate the gaps that currently exist. For
example, marketing clinical services without modifying the workflow in a way that allows
pharmacists to dedicate more time to the delivery of those services will only increase the
pressure on pharmacists and possibly lead to additional patient complaints. In contrast,
modifying the workflow while not educating the public as to the roles of different team members
does nothing to address misperceptions about support staff, thereby not addressing patient
complaints or staff morale. While it does free up pharmacist time through the delegation of
technical tasks to PTs, workflow redesign without marketing/informing patients about clinical
services could also introduce inefficiencies since the organization would not be making the best
use of its human resources. Moreover, taking tasks away from pharmacists without
counterbalancing them by creating opportunities for pharmacists to fully exercise their scope of
practice could lead to further lowered engagement and job satisfaction (Gregory & Austin, 2017;
Makowsky et al., 2013). Accordingly, this OIP proposes a hybrid approach that merges these two
solutions, which allows my organization to achieve efficiencies and effectively compete in the
new market for clinical services that was created by legislative changes (Biebricher, 2015).
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Leadership Ethics and Organizational Change
Ethical considerations are inherently weaved into my problem of practice and by
extension the OIP. For instance, ethical conduct is one of the key competencies that both
pharmacists and PTs are expected and required to demonstrate in their practice (OCP, 2012,
2015). Organizationally, there is an expectation that all employees regardless of their
professional background comport themselves in line with organizational values which emphasize
ethical conduct. Moreover, the topic of ethics in healthcare continues to be a subject of great
debate and ongoing scholarly activity (Beauchamp, 1994; Chaar, Brien, & Krass, 2005). Ethics
also feature greatly in leadership interactions with employees and has significant implications for
organizational outcomes. From a personal leadership perspective, addressing the ethical concerns
that are raised in the problem of practice, and ensuring that the path forward for my organization
aligns with my and my organization’s values is extremely important. Accordingly, this section
will examine ethical factors as they relate to the problem of practice (organizational context),
leadership approaches, and organization change.
Ethical Dimensions of the Problem of Practice
It is not surprising that ethics and pharmacy practice are deeply intertwined (Chaar et al.,
2005; Deans, 2010). From an organizational perspective, balancing a for-profit orientation with a
social professional mission and vision can cause tensions and create opposing forces that pull the
organization in different directions (Resnik, Ranelli, & Resnik, 2000). Pharmacies are at once
profit-generating businesses and places that patients turn to for healing. As a result, the
profession as a whole has attempted to impose guidelines for acceptable practices that are
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operationalized through codes of ethics2 (OCP, 2012, 2015). Additionally, and as highlighted
earlier, the focus of pharmacy practice has shifted over the years towards being more patientcentric which led to the establishment of professional responsibility principles being adopted by
the community (see Appendix) (Perepelkin & Dobson, 2009; Wingfield, Badcott, & Appelbe,
2007).
The ethical fundamentals that govern the practice of pharmacy are identical to other
healthcare professions (collectively referred to as bioethics) and include: “beneficence (the moral
obligation to benefit others); non-maleficence (to do no harm)” and “justice (fair, equitable and
appropriate treatment)” (Beauchamp, 1994; Beauchamp & Childress, 2001; Char et al., 2005, p.
196). As indicated in chapter one, my organization is committed to serving patients regardless of
their socioeconomic background and is frequently engaged in community outreach. Those are
the key values that the organization strives to adhere to, to the best of its ability, while still
maintaining fiduciary responsibility and accountability to its shareholders. However, some of the
symptoms of my problem of practice, most notably the performance of certain tasks by nonregulated support staff and the incidents where PAs have dispensed medical advice to patients,
not only represent serious ethical breaches, but also have the potential to cause serious harm.
While these incidents are not unique to my organization (Haddad, 1991; Hibbert, Rees, & Smith,
2000), this OIP needs to address these issues head-on to ensure the proper alignment of tasks
with strategy (Nadler & Tushman, 1980) and that the changes that are implemented prevent these
incidents from reoccurring. Moreover, addressing these ethical concerns represent a priority for

2

The OCP code of ethics is available from
http://www.ocpinfo.com/library/council/download/CodeofEthics2015.pdf

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

78

myself as a leader in the organization who strongly believes in the importance of taking
responsibility and modeling the behaviours I expect from my employees.
Ethics in Leadership
Ciulla (2012) noted that just because someone holds a position of power does not
necessarily mean that that individual is an effective leader, especially if they fail to meet the
ethical characteristics that are expected of them. As indicated earlier, the fast-paced and taskoriented nature of pharmacy practice precipitated a dominant transactional leadership style
(Avolio & Bass, 2002; Judge & Piccolo, 2004). Moreover, the differentiated nature of the
exchanges between pharmacists and support staff have impacted the quality of the relationships
between leaders and followers (Day & Miscenko, 2015; Erdogan & Bauer, 2014). According to
Groves and LaRocca (2011), transactional leadership is grounded in “teleological ethical
values”, also referred to as utilitarianism (p. 511). From this perspective, ethics are limited to
“whether what is being done (the end) and the means employed to do it are morally legitimate”
(Bass & Steidlmeier, 1999, p. 185). It is important to highlight that transactional leadership is not
inherently harmful to followers, rather it is founded on an individualistic view where both leader
and follower are governed by their pursuit of self-interest (Bass & Steidlmeier, 1999). While
leadership that focuses on outcomes and compliance (Groves & LaRocca, 2011) is beneficial in a
highly regulated, task-driven environment, such a view is not conducive to employee
engagement and motivation that are essential to the change process (Kotter, 2012). In other
words, leadership that is based on structured exchanges is not enough, it is equally important to
consider the relational aspects of work-based interactions.
Scholars have only recently begun examining LMX and ethical dimensions of leadership
(Mahsud et al., 2010). The relationship between LMX quality and a plethora of follower
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outcomes with ethical implications, such as commitment and counterproductive work
behaviours, have been studied extensively with a general consensus that high LMX quality is
associated with positive outcomes and vice versa (e.g., Gerstner & Day, 1997; Martin et al.,
2016). Given that LMX quality is directly linked to the differentiated nature of leader-follower
exchanges, it is important to consider how factors that inhibit LMX quality in the organization,
such as pharmacists engaging with and displaying more trust in PTs than PAs, could have
contributed to the symptoms of the problem of practice which are ethically problematic. While
there are indications that PAs who have dispensed medical advice to patients did so to avoid
complaints, it is also possible that their actions were motivated by a desire to improve the quality
of their relationship with the pharmacists by demonstrating competence or attempting to replicate
PT behaviours that they associate with higher LMX quality. It is for this reason that a structured
relational approach to leadership that considers both the transactional and interpersonal aspects
of the leader-follower relationship is appropriate for the organization and the OIP (see Figure 1).
This approach also enables me as a leader to focus organizational resources towards the very
important tasks of relationship and trust-building that are at the core of my leadership style and
philosophy, and to leverage my leadership to achieve the desired organizational outcomes.
Ethics and Organizational Change
The process of implementing organizational change is by definition rife with shifting and
complex dynamics that employ change agents and drivers to steer the organization in the desired
direction (Burnes, 2009; Weick & Quinn, 1999). The framework for change utilized in this OIP
(Kotter, 2012) is part of a larger shift in the change literature described as “emergent”
approaches (Caldwell, 2006; Kanter, Stein, & Jick, 1992). Emergent organizational change is a
“complex and incremental process of shaping how change unfolds over time” (Caldwell, 2006, p.

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

80

77). Ethical concerns as they pertain to emergent approaches to organizational change stem from
their emphasis on the role of power, politics, and influence (Burnes, 2009). A focus on achieving
outcomes and generating momentum, if not considered carefully, can easily overlook how
organizational members are impacted by change. While emergent approaches to change are, by
design, holistic and contextual (Mintzberg & Westley, 1992), issues of ethics are not always
explicitly considered (Burnes, 2009).
In describing the framework for change earlier in this chapter, I emphasized the
importance of inclusion and the engagement of all organizational members to generate buy-in
and maintain momentum (Kotter, 2012). Equally important from an ethical perspective is an
emphasis on generating consensus and empowering employees and creating a participative
environment (Wooten & White, 1999). As such, employee engagement and active involvement
in the implementation of the change initiative is a cornerstone of the plan that I detail in chapter
three. Change should not be imposed on organizational members, rather through open
communication, collaboration, and transparency, employee voices can and should be heard
throughout the initiative. While the premise of the OIP is the improvement of organizational
performance, leadership’s role in influencing and shaping change should not supersede the needs
of employees. This is especially important given the power differential that exist between
pharmacy team members. Whether intentional or not, PAs do not possess the same amount of
influence as PTs do, and as such, it is imperative that their concerns be heard, and their input
solicited at every stage. It is for this reason that I as a leader have taken the change process itself
as an opportunity to address employee equality by ensuring that PAs’ needs and roles are
emphasized and highlighted in the organization, so that they understand that their contributions
are vital and critical to the organization’s functioning. Doing so in a thoughtful and proactive
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manner will also go a far way in generating organizational change that is enduring (Wooten &
White, 1999).
Ethics and Neoliberalism
As indicated earlier, this OIP has, for the most part, approached the problem of practice
from a neoliberal perspective. At first glance, addressing ethics and its importance in my
organization may seem paradoxical when viewed from a neoliberal lens. Indeed, the issue of
moral responsibility and ethics in neoliberal thought has become a topic of interest for scholars
(cf. Bloom, 2017; Davies, 2014a), especially post the 2008 economic crisis that was blamed in
large part on neoliberal policies that deregulated financial markets (Bloom, 2017). Scholars posit
that far from being a hyper-capitalist, greed-driven philosophy, neoliberal thought and principles
are responsible for the emergence of “business ethics” and “corporate social responsibility” as a
means of self-regulating (Shamir, 2004). Viewed from this perspective, codes of conduct and
organizational values are tools that corporations use to regulate themselves “in order to act
legally in their pursuit of profit” (Bloom, 2017, p. 11).
One of the renowned scholars in neoliberalism, William Davies, in his seminal work The
Limits of Neoliberalism suggests that the universal drive for competition that was championed by
neoliberal thought was not structured entirely by the desire to achieve efficiency and increase
productivity, but also by the intrinsic human need for achieving happiness and promoting wellbeing (Davies, 2014b). In other words, satisfaction, happiness and well-being are as much goals
of a neoliberal society as is profit (Davies, 2015). While a full exploration of this new stream of
academic work is beyond the scope of this OIP, my main thesis is that ensuring that patient and
employee well-being and satisfaction are being addressed is not antithetical to a neoliberal
perspective. To the contrary, pursuing these goals, which are at the foundation of my leadership
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philosophy, I believe, will yield positive outcomes to my organization and the communities it
serves and are in line with the approach to change which I have taken in this OIP.
Chapter Summary
Chapter two highlighted the potential that adopting a Structured Relational Leadership
approach has in supporting this OIP. Kotter’s (2012) Organizational Change Framework was
used to provide a phased process for introducing, implementing, and sustaining change in the
organization. A critical organizational analysis utilizing Nadler and Tushman’s (1980)
Congruence Model revealed areas of misalignment and lack of fit in the organization that
corresponded to the symptoms of the problem of practice and that were used to put forth possible
solutions. Finally, I highlighted the ethical implications of the OIP as they pertain to the
organizational context, the leadership approach, and the change initiative. Chapter three will
delve into the details of the change initiative and will introduce Deming’s (1994) PDSA cycle as
the foundation for the implementation of the change plan.
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Chapter 3: Implementation, Evaluation and Communication
While chapter two provided an in-depth analysis of the organization and put forward
proposed solutions for change, chapter three’s overall objective is to chart out a detailed path
forward for the organization towards the attainment of the desired future state. Accordingly,
chapter three comprises three distinct, but complementary and connected components: the
change implementation plan; a change process monitoring and evaluation strategy; and a plan to
communicate the need for change and the change process. While each topic will be addressed indepth in its respective section, all three aspects of the change initiative are intrinsically linked
and will unfold simultaneously building on and feeding into each other.
Change Implementation Plan
In order to properly tackle the concerns outlined in the problem of practice, the OIP will
focus on the two main solutions that were proposed in chapter two: the development and
implementation of a patient-focused education initiative and redesigning the pharmacy
workflow. These two solutions were selected because together they address the following
overarching dimensions of the problem of practice and the OIP: safety concerns; employee
engagement and morale; patient satisfaction and perceptions relating to pharmacy staff; and
suboptimal organizational performance.
Evaluating each of the proposed solutions in chapter two revealed that no single approach
could address all the above dimensions. Given the interconnected nature of the problem of
practice’s symptoms, as described in chapter one, a comprehensive approach is therefore
necessary in order to anchor and institutionalize change within the organization and to maximize
the chances of success (Cawsey et al., 2016; Kotter, 2007, 2012). The implementation plan for
the two solutions will be guided by Kotter’s (2012) change framework, which was described in
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detail in chapter two. The details and steps involved in the implementation of the two solutions
will be discussed in detail below.
Selecting the Change Agents
For each of the solutions, a guiding coalition will be created to lead the implementation
(Cawsey et al., 2016; Kotter, 2012). In addition to being in line with the OIP’s change
framework, this approach was chosen because it ensures that stakeholders from various levels
and groups in the organization are represented and consulted which can contribute positively to
engagement and buy-in, and facilitate communication (Calegari et al., 2015; Hoadly & Lamos,
2012). Each team will be comprised of the Chief Pharmacist, the CHRO and representatives
from the pharmacist and support staff cadres (PT and PA). One of the reasons that two separate
teams (one for each solution) are needed is to not overload employees who, in addition to being a
part of the guiding coalition, still need to carry out their functional duties (Bliese & Castro, 2000;
Quinn, 1988; Vakola & Nikolaou, 2005). Given that senior leadership in the organization will
have to be involved in both guiding coalitions, it is for this same reason that one concern that
needs to be monitored closely is senior leadership’s ability to contribute effectively to both
solutions while carrying out their regular duties. Mitigating this concern will be discussed in the
limitations section of this chapter. Given the nature of the changes, there is no expectation that
ParentCorp will participate in either guiding coalition since it does not play a direct role in the
daily operations of the organization and its permission is not required to approve or enact the
proposed changes. In describing the implementation of both solutions below, I ensured that the
actionability and timeliness of the plan was highlighted by identifying short, medium and longterm goals and steps (Bolman & Deal, 2013; Cawsey et al., 2016). Given that the organization is
owned by two partners (myself and the Chief Pharmacist), an underlying assumption of the
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implementation plan is that the costs that would be incurred will be approved and authorized.
With an average operational cost (wages and expenses) of $2.5 million dollars annually per
pharmacy (Organization X, 2017c), the cost of implementing both solutions could be considered
part of the regular operational expenses3.
Solution One: Patient Education Initiative
The main goal for this solution is to develop a comprehensive educational initiative
aimed at providing the public with accurate information regarding pharmacy member roles and
pharmacy-based clinical services that are available to them. One key objective for this part of the
plan is to improve patient safety through the reduction of incidents where support staff members
provide unqualified medical advice (Nasra, 2018a; Organization X, 2016a, 2017a). By clearly
defining support staff roles and educating the public, two additional related objectives for this
solution are improving patient satisfaction and perceptions of support staff as well as employee
morale and engagement.
Table 6 below outlines the steps involved in the implementation of the patient education
initiative as well as a breakdown of the resources and the timeline required for implementation.
The details of the implementation plan will then be discussed in the remainder of the section.

3

While annual budgets are set by Organization X, the franchise-ownership model allows owners/partners discretion
over operational expenditures (e.g., overtime wages, purchase of materials, training etc.)
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Table 6
Solution One Implementation Details
Implementation Process/Steps
Resources
1. Develop educational material Design and produce
to highlight pharmacy team
signage/posters for pharmacy.
member roles.
Design and produce pamphlets
for patient distribution.
Cost: Variable but minimal
given availability of printing
resources within pharmacy.

Timeline
Short-term: 1-2 months

2. Obtain educational material
describing expanded scope of
practice for pharmacists from
Ministry of Health and LongTerm Care.
2a. Obtain permission to use
educational material or
modify internally.
3. Decide on changes to support
staff uniforms.

Materials from Ministry of
Health & Long-Term Care.
Produce printed pamphlets for
patient distribution.
Cost: variable but minimal given
availability of printing resources
within pharmacy.

Short-term: 1-2 months

Order new uniforms from
supplier.
Produce pharmacy signage
explaining the changes.
Cost: Normal part of operational
costs since uniforms are ordered
on regular basis. Minimal cost to
printing signage given
availability of printing resources
in pharmacy.

Short-term: 3-5 months

4. Develop schedule for “clinic
days” for specific interventions
and clinical services (e.g.,
diabetes, hypertension).

Additional staff required for
clinic days.
Cost: Variable depending on
number of hours. Wage
estimates are:
- Pharmacist: $45-$55/hr
- PT: $22-$26/hr
- PA: $14-$25/hr

Mid-term: 3-5 months

5. Change roll-out:
5a. Distribute educational
materials
5b. Schedule clinic days
5c. Implement new uniforms

Long-term: 6 months - ongoing
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Short-term. During the first two months, the guiding coalition’s main activities will be
focused on the development of educational materials for patients. First, the team will produce
informational material explaining the roles and responsibilities of each pharmacy team member.
The content will be developed by referring to formal documentation from the OCP (OCP, 2012,
2015), the National Association of Pharmacy Regulatory Authorities (NAPRA, 2014), and
internal organizational documentation (ParentCorp, 2015). The guiding coalition will also solicit
input from organizational members regarding changes that will be made to pharmacy team
uniforms so that patients can easily distinguish between team members. Additionally,
educational material regarding the expanded scope of practice/clinical services that are available
to patients will be obtained from the Ministry of Health & Long-Term Care in both official
languages to inform patients about the range and the benefits of pharmacy-based clinical services
that are available to them (Ministry of Health & Long-Term Care, 2016). Once the materials
have been obtained and tailored to organizational needs, they will be printed internally, as is
done regularly for other signage and educational material, and the new uniforms will be
procured. The educational material will be provided to patients in either official language, since
patient preference is logged in the patient profile.
Mid-term. The next task that guiding coalition will undertake is related to developing a
sustainable and efficient approach for the delivery of clinical services in the pharmacy. This will
involve the scheduling of “clinic days” during which dedicated staff will be available to
administer clinical services to patients, as well as provide educational resources related to the
management of chronic diseases such as diabetes and hypertension. This task is critical to the
success of the educational initiative as it allows patients to book appointments with pharmacists
and know beforehand when dedicated personnel will be available to answer their questions and
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address their concerns. While pharmacists will continue to attend to patient needs during every
shift, having clinic days will enable the pharmacy to better manage staff time and pharmacists’
workload. Research findings also indicate that interventions such as clinic days in pharmacies are
related to better patient outcomes when it comes to managing health conditions such as diabetes
and smoking cessation (Cranor, Bunting, & Christensen, 2003; Kennedy, Giles, Chang, Small, &
Edwards, 2002).
Long-term. Once the educational materials have been finalized, clinic day scheduling
completed, and the new uniforms have been procured the next step will be incorporating the
changes and rolling-out the initiative. It is expected that this step will take place at the six-month
milestone and over time, the changes will become an ongoing part of the daily operations in the
pharmacy. While an updated schedule for clinic days will be provided on a monthly basis, the
frequency of clinic days will be modified as required by demand (which will also be addressed in
the monitoring section of this chapter). The distribution of educational material will be rolled out
as follows:
•

Existing patients: At the next prescription pickup, pharmacy support staff will include the
materials with the patient’s medications and will take a few minutes to go over the
content. Patients will also be provided a schedule of upcoming clinic days. Depending on
a patient’s profile, relevant clinic days will be highlighted should the patient wish to
make use of them. Patients will also be informed that counseling is available to them
outside of clinic days should they require it. Once the information has been provided, a
note in the patient’s profile will be made.
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New patients: Materials regarding pharmacy staff and available services will always be
provided at the first transaction, after which materials will be provided in the same
manner as existing patients.
Understanding stakeholder reactions and managing the transition. It is important

when introducing change within the organization to take into account how stakeholders may
react to or perceive change (Cawsey et al., 2016). When it comes to introducing clinic days, there
may be initial resistance from patients who may perceive that these changes are being
implemented to augment the pharmacy’s profit (Austin et al., 2006). However, by providing
official materials, and being transparent about the costs and the revenue generated by these
activities, this may mitigate some of these concerns, especially by highlighting the voluntary
nature of these services and that they are a part of a larger strategy to manage pressure on the
healthcare system (Guirguis et al., 2014).
Providing clinical services will require dedicated pharmacy staff time. As such, during
scheduled clinic days, it will be necessary to have a second pharmacist on staff. By scheduling
these days ahead of time, it will be possible to allocate resources accordingly. It can be expected
that the revenue that will be generated through these services will help offset the labor costs
associated with having additional staff members during each shift (Ministry of Health and LongTerm Care, 2016). Changes in the uniform are not expected to generate resistance within the
organization since staff will be consulted ahead of time and their input will be solicited prior to
deciding on the final uniform choice. Ensuring broad consultation and transparency as to the
reasons behind these changes as well as the anticipated benefits will allow employees to voice
any concerns they may have, and for those concerns to be addressed and taken into
consideration. Moreover, having pharmacy support staff representatives on the guiding team will
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assist in socializing these changes in the rest of the organization and will emphasize the rationale
for the change.
Maintaining momentum. It is possible that after several months, pharmacy staff may
become complacent about providing educational materials to new patients and that the
scheduling of clinic days may not be prioritized. It is important therefore for the guiding team to
ingrain these practices in daily activities. This can be done through incorporating these activities
in SOPs, posting signage, and overseeing the monthly scheduling until such time that these
activities become a part of the regular operations of the pharmacy. Incorporating feedback on
these changes during regular performance appraisals can also help in maintaining momentum
(Buchanan et al., 2005).
Solution Two: Redesigning Pharmacy Workflow
The main goal of the second solution for the OIP is to make changes to the pharmacy’s
workflow in order to address pharmacy performance suboptimization (Bolman & Deal, 2013). In
order to achieve that, this solution’s key objectives and priorities revolve around delineating
tasks that PTs can perform exclusively and formalizing the role of PAs in order to reduce role
overlap and enable proper task delegation in the pharmacy. When implemented, in addition to
improving pharmacy performance, a properly designed workflow can also improve employee
engagement and job satisfaction (Angelo & Ferreri, 2005; Lin, et al., 2008).
Table 7 below outlines the steps involved in redesigning the pharmacy workflow as well
as breakdown of the resources and the timeline required for implementation, with the details
expanded upon and discussed in the remainder of this section.
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Table 7
Solution Two Implementation Details
Implementation Process/Steps Resources
1. Analyze current workflow to
identify role overlap and task
delegation opportunities.
2. Guiding team puts forth new
workflow proposals for
consultation with stakeholders;
makes changes as required; and
finalizes new workflow design.
3. Prepare for new workflow
implementation:
3a. Map out new Information
Technology (IT)
requirements and processes
3b. Develop new SOPs and
working aids.
3c. Develop training
materials.
3d. Physical modification of
pharmacy layout (if required)
3e. Installation of new IT
system

Timeline
Short-term: 1-2 months

Short-term: 3-4 months

Training materials developed
internally by CHRO
Working aids, SOPs, new
resources and references
developed by guiding team
New IT terminal
Cost: $6,000
Installation of IT terminal &
modifying software
Cost: variable but can range
from $1,000-$2,000
Physical changes to pharmacy
layout
Cost: variable and dependent on
scope of changes required.

Mid-term: 5-10 months

4. Train pharmacy staff on new
workflow.

Mid-term: 10-12 months

5. Launch new workflow

Long-term: 12 months for
launch

Short term. The first task that the guiding coalition will undertake is to analyze the
existing pharmacy workflow. This will be done by mapping out all the subtasks involved in the
filling of prescriptions to pharmacy team member roles (pharmacist, PT, or PA). The analysis
will highlight areas of overlap as well as the subtasks which can be delegated to PTs under their
regulated authorities. The guiding coalition will then work to produce proposals for the new
workflow design that at a high level should emphasize efficiency and quality control (Aguilar et

ENABLING ORGANIZATIONAL CHANGE IN PHARMACY PRACTICE

92

al., 2013; Angelo & Ferreri, 2005; Nold, 2011). The new workflow also needs to meet two main
criteria: to minimize overlapping tasks and distinguish tasks that PTs can perform independently
(Nold, 2011; Pai, 2005). The guiding team will then consult organizational members and seek
their input on the proposal. This step is critical because ensuring buy-in for a significant change
such as this one is essential (Cawsey et al., 2016; Kotter, 2012). Engaging with the impacted
stakeholders also demonstrates senior leadership’s commitment to transparency and building
trust, which are hallmarks of this OIP’s Structured Relational Leadership approach. Once
employee feedback has been incorporated, the guiding team will finalize the new workflow.
Mid-term. After approving the new workflow, the next step would be to prepare for its
implementation and launch. I, as CHRO will lead the development of the training material for
pharmacy staff on the new workflow. The guiding coalition led by the Chief Pharmacist and
CHRO will also develop new SOPs and working aids that will replace the existing ones. The
current IT software employed at the organization contains all the different modules that would
encompass any workflow design. As such, no new software purchase will be necessary, however
minor adjustments to permissions could be required to allow PTs access to specific modules.
Additionally, a new IT terminal for PTs will be also be needed. The services of IT professionals
will be required to make the necessary software modifications and install the new system. The
new workflow might also necessitate some physical changes in the layout of the pharmacy which
will need to be completed prior to launch.
Long-term. Depending on the progress that is achieved during the mid-term goals, the
guiding coalition will determine a hard launch date for when the new workflow implemented; but
it is expected to be scheduled around the twelve-month mark. Once implemented, the guiding
coalition will need to closely monitor the pharmacy’s performance as well as solicit the input of
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pharmacy team members to make sure that the transition to the new workflow is smooth and that
any unforeseen issues are quickly addressed. Details regarding the monitoring and evaluation of
the implementation plan will be discussed later in this chapter, however, over time, employee
feedback will continue to be solicited, and minor changes made to the new workflow processes to
further improve it in order to ensure lasting long-term success.
Managing stakeholder reactions. Changing a workflow is a complex endeavor and
requires extensive analysis and planning (Angelo & Ferreri, 2005). There are several possible
implementation issues that may arise, chief among them is resistance to change. One of the
outcomes of the new workflow is the formalization of the pharmacist-PT delegation process
which entails pharmacists giving up some of their current authorities so that PTs take on new
responsibilities. Research has shown that individuals don’t usually respond positively to giving
up “power” (Pojskic et al., 2014). Having a pharmacist representative in the guiding team can
help mitigate this concern, however special attention needs to be afforded to explaining why task
delegation is necessary and to frame it positively to the pharmacists (e.g., in the long-term it
frees them up to perform clinical tasks) in order to minimize the chances of resistance (Fairhurst
& Sarr, 1996).
Managing the transition. Another implementation issue is related to support staff
perceptions. Formalizing the new PT role may have a negative impact on PA morale. In the old
workflow, PTs and PAs performed the same tasks. The new workflow would limit the scope of
tasks that PAs can perform, and they may perceive that they have less “status” in the
organization. To mitigate this, the guiding team needs to highlight that PAs play a critical role in
the new workflow; that they are an integral part of the team; and that their contributions are
essential to pharmacy functioning. This is also a key area where the proposed Structured
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Relational Leadership approach can play a significant role. Both senior leadership and
pharmacists need to pay careful attention to their interactions with support staff to ensure that
both groups feel valued and included, which can improve perceived fairness (Maslyn & UhlBien, 2001). High quality leader-follow relations that empower employees and that demonstrate
genuine empathy can go a long way in mitigating some of the anxiety that the new work
structures may cause (Bauer & Erdogan, 2015; Mahsud et al., 2010).
Maintaining momentum. Given that the actual launch of the new workflow isn’t
expected to take place for at least twelve months, it is important for the guiding team to ensure
that momentum is maintained and that the plan stays on track. Setting a hard launch date,
consulting stakeholders, and the training that employees will be required to complete will help to
ensure that team members remain engaged throughout the change process. Frequent and
effective communication, which will be addressed later in the chapter, will also play a critical
role maintaining momentum and keeping employees galvanized (Klein, 1996). The fact that the
new workflow requires physical changes in pharmacy layout and IT system modifications will
help institutionalize the change, making it difficult to revert to the old way of doing things.
Limitations
The proposed implementation plan poses several limitations that I, as CHRO, need to be
mindful of throughout the initiative. One of the major concerns, which also extends to the
monitoring and evaluation strategy and the communication plan, relates to implementing the two
proposed solutions concurrently. A concurrent approach is required in order for the change plan
to address the main factors implicated in the problem of practice. The analysis of the proposed
solutions that was conducted in chapter two revealed that no single solution can adequately
address all these issues simultaneously, making it necessary to implement two separate, albeit
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complementary solutions. I explored the option of implementing the solutions consecutively,
however, due to the inter-related nature of the solutions, that was not deemed to be an ideal
approach. For instance, modifying the pharmacy’s workflow is directly related staff roles,
making it necessary for the patient education initiative to incorporate those changes. Similarly,
the redesigned workflow will allow pharmacists to dedicate more time to the delivery of clinical
services, which also necessitates the deployment of a plan focused on educating patients on the
services available to them.
The main issue that arises from the concurrent implementation is over-extending the
organization’s resources and the ability to manage both initiatives successfully at the same time.
As highlighted earlier, each solution proposes the formation of a dedicated guiding coalition that
is comprised of senior leadership and representatives from the pharmacist and support staff
cadres. While it is possible, in fact recommended, that the staff representatives be different for
each team, the Chief Pharmacist and CHRO are by default required to be part of the team
guiding each solution. This runs the risk of senior leadership not being able to devote enough
time or effort to either initiative, which can have detrimental effects on the outcomes of the plan.
Being mindful of this risk, I attempted to at least partially mitigate it through the careful planning
and scheduling of the steps for both solutions as they are being implemented.
The presence of senior leadership in both teams, however, has its benefits, which will be
elaborated on in the sections that follow. It allows them to monitor progress, and to shift
resources as required in order to maintain momentum and ensure that adequate progress is being
made. Having different staff representatives on each of the guiding teams is also beneficial for
several reasons. First, by involving more organizational members in the change effort, employee
engagement and buy-in can be enhanced. Second, communication between staff members
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regarding the implementation of the two solutions can elicit unique insights that senior
leadership may not be able to gain independently. The cross-pollination of ideas and discussions
around the progress that is being made can also reveal issues or concerns (e.g., employee
resistance) which allows the guiding team to address them proactively and in a timely manner.
Another concern or possible limitation of the proposed approach has to do with the scope
of change and the relatively compressed timeframe over which it is being implemented. At first
glance, the scope of change may seem extensive. A careful consideration of the outcomes of
change, however, reveals that it is in fact targeted towards addressing the symptoms of the
problem of practice. Workflow changes cannot be implemented sequentially, as such, staggering
the implementation of the plan over several phases is not possible due to resource dependencies
and the sequential nature of the tasks performed in a workflow (Angelo & Ferreri, 2005).
Additionally, the amount of time that is being dedicated to each plan is based on estimates of
similar initiatives that had been completed in previous years (ParentCorp, 2010). That said, given
that the launch date of the new workflow won’t be set until after all the preparations have been
completed (mid-term goal), through the careful monitoring of progress, that date can be adjusted
to account for unforeseen delays or additional changes that may need to be made to the plan.
A final limitation that I need to be cognizant of is that throughout the change initiative
and all its steps, regular pharmacy functions cannot be disrupted. Pharmacy operations must
continue as normal in order for the organization to maintain its obligations to both patients and
ParentCorp. This necessitates a careful consideration of how resources in the pharmacy are being
utilized (e.g., pharmacy staff time), and can require that some activities take place outside regular
work hours (e.g., changing physical layout of pharmacy, installation of IT terminal). As such
additional costs may be incurred such as overtime for employees who are involved in the change
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initiative, that are difficult to determine early on. This concern is specific to the workflow
redesign, because the majority of the changes that are being implemented are not “patientfacing”. In other words, a seamless transition between the old workflow and the new one once it
is launched is essential to ensure that patients are properly served and that their healthcare needs
are being met effectively without interruption.
Being aware of the limitations surrounding the implementation of the change plan brings
to the fore the importance of monitoring the progress of the implementation as well as evaluating
the change initiative once it is rolled out. Being able to assess outcomes is extremely important,
but so is monitoring change as it unfolds because it enables the guiding team to introduce course
corrections should unforeseen circumstances arise. As such, designing a robust monitoring and
evaluation strategy is an integral part of the OIP and will be discussed next.
Change Process Monitoring and Evaluation
Kotter’s (2012) change framework, as described in chapter two, provides for a detailed
blueprint for organizational change. It is however lacking into key areas that are integral to the
success of any OIP, analysis and evaluation. Chapter two addressed the organizational analysis
aspect by utilizing Nadler and Tushman’s (1980) Congruence Model to identify areas of the
organization where misalignment and lack of fit have contributed to the problem of practice.
However, implementing a comprehensive change plan that combines workflow redesign with a
public education initiative, also requires a systematic approach that explicitly incorporates
progress monitoring and evaluation into the change process.
Plan, Do, Study, Act
Deming’s (1994) Plan-Do-Study-Act (PDSA) cycle for change represents a cyclical
staged approach that can be used at a macro level to visualize and organize the change process.
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The PDSA cycle is an iterative process-based model that is used extensively in healthcare quality
improvement (Varkey, Reller, & Resar, 2007) and in many other industries and organizational
contexts (Moen & Norman, 2010). At a high level, during the “plan” stage, all the aspects of the
change initiative (who, what, where, and when) are identified, and the steps of the change plan
are clearly put forth. During this phase, the resources that are required are also identified and a
strategy for data collection for the purposes of monitoring progress and evaluating the outcomes
of change is also outlined (Langley, et al., 2009). Once the planning has been completed, the
implementation of change (i.e., the “do stage”) begins. It is during this stage that data for
monitoring and evaluation is collected. During the “study” phase, analysing the progress and
outcomes of change takes place to ensure that the plan is unfolding as expected. Based on the
findings of the “study” phase, a refinement and modification of the change process, if necessary,
is incorporated into the change plan and a new PDSA cycle starts allowing for further
enhancement and ensuring the continuous improvement of the change process (Deming, 1994;
Moen & Norman, 2010).
Langley, Nolan, and Nolan (1994) put forth three questions that made the emphasis on
monitoring and evaluating change more explicit within the PDSA cycle: “What are we trying to
accomplish? How will we know that a change is an improvement? What change can we make
that will result in improvement?” (Langley et al., 1994; Moen & Norman, 2010). By considering
these questions we can determines apriori how progress will be assessed (Donnelly & Kirk,
2015; Leis & Shojania, 2016). Table 8 below addresses these questions as they relate to each of
the two proposed solutions.
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Table 8
PDSA Cycle Change Improvement Questions
Question
Solution 1
What are we
• Improve patient
trying to
perceptions of pharmacy
accomplish?
staff

•
•
•

How will we
know that a
change is an
improvement?

Data collected:

•
•
•

What change
can we make
that will result in
improvement?

Improve patient
satisfaction
Reduce safety incidents
Improve morale and
engagement

Patient satisfaction
surveys
Employee engagement
surveys
Metrics on safety
incidents (number of
incidents every month)

Based on analysis of collected data,
changes to the education initiative
can be introduced and modifications
made.

Solution 2

•
•
•
•

Reduce suboptimization due to
role overlap
Improve pharmacy performance
Reduce dispensing errors
Improve employee engagement
and morale

Performance metrics:

•
•
•
•

Wage-cost-per-script
Average time to fill Rx
Employee engagement surveys
Dispensing error rates

Based on analysis of collected data, further
enhancement on new workflow can be
made.

As can be noted in the table, the answers to the question “what are we trying to
accomplish” clearly map onto the dimensions of the problem of practice that the two solutions
aim to address; in other words, closing the gap between the current and future states that exists in
the organization (Langley et al., 2009). The responses to the second question set out the various
key performance indicators (KPIs) and metrics that can be used to determine whether change has
been successful. These will be further elaborated in the following section.
Monitoring and Evaluation Strategy
Traditionally, monitoring has been described as occurring during implementation while
evaluation is conducted post-change and focuses on analysing the outcomes (Neumann, Robson,
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& Sloan, 2018). This temporal distinction between the two functions can be somewhat
misleading as it de-emphasizes the fact that monitoring and evaluation are results-based and
ultimately focus on accountability and performance (Park, 2017). Moreover, by limiting
evaluation to the end of a change initiative, leaders may not be realizing the benefits of ongoing
feedback and may be missing out on important opportunities to further improve the change plan.
Bunker (1978) clearly articulated that “the potential value of evaluation is realized … only when
one treats it as an ongoing feedback component of the change process. … In this way, evaluation
is used to generate data to help keep the program on target” (as cited in Jones & Rothwell, 2017).
As such, for the purposes of the OIP, I will use monitoring and evaluation interchangeably, and
will instead take a multiphase approach in developing a comprehensive strategy (Park, 2017). To
ensure that monitoring and evaluation are properly integrated in the OIP, these critical steps
should be done pre-intervention, during implementation (intra-implementation) and postintervention (Park, 2017). Pre-intervention evaluation was covered through the critical
organizational analysis that was performed in chapter two, and the results of that evaluation were
used to set the objectives for the OIP.
Intra-implementation monitoring and evaluation. As a change initiative unfolds
within an organization, it is essential that ongoing observation of progress takes place so that
modifications to the plan can be made to mitigate challenges as they arise (Bolman & Deal,
2013; Neumann et al., 2018). This is especially critical in my organization where two solutions
are being implemented concurrently. For both solutions, monitoring the progress of
implementing the change plan will be led by the guiding coalitions. During weekly meetings,
members of each team will produce progress reports to document whether tasks specific to each
stage have been completed. Conducting regular meetings in short intervals has been
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recommended by scholars as it allows for feedback to be continuously collected and assessed
(Cummings & Worley, 2008). Weekly meetings will also allow the guiding team to discuss
future milestones and deliverables, and to assess how the change initiative is being received
throughout the organization. These weekly meetings will enable the representatives of each
employee group (pharmacists, PTs, and PAs) to engage with senior leadership and report any
concerns that employees may have. This type of stakeholder engagement throughout
implementation can help identify and mitigate resistance or opposition to change which is a
major concern for any OIP (Carnall, 1986; Ford, Ford, & D’Amelio, 2008; Peltokorpi, Alho,
Kujala, Aitamurto, & Parvinen, 2008). In addition to weekly meetings, senior leadership will
hold monthly organization-wide meetings to update all employees on the status of the change
initiatives. These meetings will also act as a forum for soliciting feedback and input, which is in
line with the Structured Relational Leadership approach advocated by this OIP. By directly
engaging with all employees, senior leadership can demonstrate transparency and openness,
which can enhance trust, employee engagement, and promote buy-in (Bauer & Erdogan, 2015;
Cawsey et al., 2016; Kotter, 2012).
Post-intervention monitoring and evaluation. Once the change initiative has been
implemented, the focus of monitoring and evaluation shifts more towards the results. In other
words, answering the question: was change achieved? And if so, was it successful in addressing
the gaps outlined in the OIP? (Cummings & Worley, 2008; Kaufman & Keller, 1994; Park,
2017). Table 3 had outlined the data (i.e., metrics) that will be collected during the “do” stage of
the PDSA cycle, which will be analysed during the “study” phase in order to both assess
effectiveness and determine whether further changes are needed (prior to starting another PDSA
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cycle). The strategy for monitoring and evaluation post-intervention strategy is therefore
determined largely by the solution and its overall aims as discussed below.
Solution one. For the first solution, launching a patient education/information initiative,
requires that evaluation focus on both patient feedback as well as examining internal
organizational outcomes. While the solution itself is not a training intervention per se, given that
the intention is to change patient perceptions, and by extension behaviour, using components of
Kirkpatrick’s (1998) evaluation model can provide critical insights into the effectiveness of the
intervention (Kaufman & Keller, 1994). Table 9 below provides an overview of the four-levels
of Kirkpatrick’s (1998) evaluation approach, as well as how they map onto the monitoring and
evaluation strategy for this solution.
Table 9
Application of Kirkpatrick’s (1998) Evaluation Model to OIP’s First Solution
Description
Solution 1 application
Level 1
Reaction (how patients feel about
• Patient survey on
intervention)
educational material

•

Level 2

Learning

Level 3

Behaviour (to what extent has the
intervention transferred over/is being
implemented)

Not Applicable

•
•
•

Level 4

Results (organizational benefits)

Patient survey on clinic days

•
•

Appointments scheduled for
clinic days
Number of requests for
clinical services
Frequency of misidentifying
pharmacy team members
Employee engagement
surveys
Number of safety incidents

For the purposes of the OIP, I am interested in whether patients find the provided
information material about the different roles of pharmacy team members as well as the
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information regarding clinical services and the availability of clinic days useful (Level 1). As
such, very short surveys that gauge patients’ reactions to the provided information will be
conducted at the time that the material is delivered (i.e., prescription pickup). The results of these
surveys will be analyzed on a monthly basis to gauge their utility and modifications will be
incorporated as necessary. Additionally, changes in patient behaviour in two main ways will also
be assessed (Level 3). Uptake in scheduling appointments for clinic days and requesting clinical
services during regular visits will also be measured on a monthly basis. Analysing this data will
allow the organization to modify the scheduling of clinic days, and allocate resources
accordingly (e.g., additional staff members during shifts). Moreover, during clinic days, patient
feedback will also be solicited as to whether they found the services to be useful (Level 1), and
changes in patient behaviour when it comes to managing chronic diseases or drug compliance are
additional indicators of intervention effectiveness (Level 3). Finally, when it comes to evaluating
the impact of uniform changes, metrics regarding patient’s misidentifying pharmacy team
members, and patient satisfaction surveys will also be analyzed on a monthly basis (Level 3).
The impact of these changes on employee morale and engagement will also be evaluated on a
quarterly basis through employee surveys. Changes in the frequency of safety incidents is a
Level 4 organizational outcome that will be assessed every six months.
Solution two. Modifying the pharmacy workflow is an internal change which will not be
visible to patients. Monitoring and evaluation efforts therefore will be directed towards internal
stakeholders (i.e., pharmacy team members) and performance metrics. As noted earlier,
extensive stakeholder consultation will take place pre-implementation, and employee input will
inform the changes that are enacted in the new workflow. Once the new workflow is launched, it
is critical to gauge employee reactions on a regular basis to identify any unforeseen challenges or
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impacts that may need to be rectified immediately (Park, 2017). As such, short employee surveys
focusing on their reactions to the new workflow will be conducted on a weekly basis for the first
month and on a biweekly basis during the second month. Following that, questions regarding the
new workflow will be incorporated in the annual employee satisfaction survey. Informal
feedback will also be solicited on a regular basis during weekly team huddles. Given that one of
the aims of the new workflow is to address employee engagement and morale (especially support
staff), employee engagement surveys will be conducted on a monthly basis for the first three
months, and then on a bi-annual basis. Finally, since modifying the workflow is intended to
address performance suboptimization, the following three metrics will be assessed on a monthly
basis as part of the pharmacy’s regular performance evaluation: WCPS, average time to fill a
prescription, and the number of dispensing errors.
Plan to Communicate the Need for Change and Change Process
One of the most vital components of a change plan that can shape the outcomes of
initiatives within organizations is communication (Cawsey et al., 1996; Goodman & Truss, 2004;
Kotter, 2012). A well-planned communication strategy can play a crucial role in almost every
aspect of the change plan, from explaining the need for change and its objectives (Armenakis &
Harris, 2002; Russ, 2008), to generating buy-in and gaining support (Kotter, 2012), and
informing organizational members about the progress of the change initiative (Klein, 1996). A
properly executed communication plan allows leaders to alleviate uncertainty and improve
morale within the organization (Campbell, Carmichael, & Naidoo, 2015; Klein, 1996), while
ineffective communication has been linked to the failure of organizational change (CoulsonThomas, 1997). It is therefore no surprise that communicating organizational change has been a
widely researched topic with a vast body of academic literature and scholarly research (cf. Lewis
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& Seibold, 1998). In this section, I outline the communication plan and strategy that will be used
in the implementation of my OIP.
One of the key factors that I considered in formulating the communication plan is its
compatibility with both the change framework and the leadership approach employed in this
OIP. Additionally, for communication to be effective, leaders should not only focus on the
strategies and methods for communication, but also on the content of the message as that is what
“both conveys the nature of change and shapes the sentiments that determine reactions to the
change” (Armenakis & Harris, 2002, p. 169). Accordingly, I will use the five key change
message components proposed by Armenakis and Harris (2002) to formulate consistent and
accurate messaging. I will then employ Klein’s (1996) communication strategy framework as the
blueprint for the communication plan for this OIP.
Communication Content
In order for a communications plan to be effective, leaders need to ensure that they
deliver effective, consistent and clear messaging to stakeholders throughout the change initiative.
Scholars emphasize the importance of the change message and its content, highlighting that it
serves to coordinate the phases of change “by providing the organizing framework for creating
readiness and the motivation to adopt and institutionalize change” (Armenakis & Harris, 2002, p.
169). Armenakis, Harris, and Field (1999) identified five distinct and key focuses that the change
message should be framed around: discrepancy, efficacy, appropriateness of change, principal
support and personal valence.
Discrepancy. Discrepancy has to do with demonstrating the need for change by
highlighting the gap that exists between the organization’s current state and the desired state. In
my organization, this would involve conveying to stakeholders how the organization’s current
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performance falls short from expected standards. Senior leadership can rely on past metrics of
employee engagement and patient satisfaction, as well as dispensing error rates and safety
incidents to emphasize why change is needed. In highlighting these gaps and concerns as well as
the risks involved in maintaining the status quo, leaders not only explain the need for change, but
if done effectively, communication can ignite a sense of urgency (Kotter, 2012).
Efficacy. It is not enough to highlight that something is wrong in the organization in
order to gain stakeholder buy-in. When communicating the need for change, leaders should seek
to assure stakeholders that the organization possesses the resources and the means to successfully
implement change; in other words, leaders need to project confidence in the ability of the
organization to succeed. Efficacy is directly linked to stakeholder motivation (Bandura, 1986),
which is a critical ingredient in galvanizing organizational members around the change effort and
generating momentum (Kotter, 2012). In my organization, this would be reflected in leaders
clearly communicating the organization’s commitment to change, and the dedication of the
necessary resources (e.g., financial, personnel, etc.) for the proposed plan.
Appropriateness of change. Once the need for change has been established, it is critical
that leaders explain and gain support for their vision and plan for change. Organizational
members may agree that change is needed, but they may disagree with the specific solutions that
are being proposed. Communicating the rationale behind the chosen solutions is therefore central
to generating buy-in and gaining support (Kotter, 2012). In order to garner support, senior
leadership will present the findings of the critical organizational analysis to stakeholders, as well
as the benefits and drawbacks of the various possible solutions to addressing the gaps in the
organization. Specifics regarding the communication strategy will be provided in the section that
follows, but by clearly articulating the reasoning behind the choices that have been made, leaders
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can address stakeholder concerns as well as link the diagnosis (e.g., increased safety incidents
and performance suboptimization) with the proposed solutions (e.g., redesigning old workflow
and educating patients) (Armenakis & Harris, 2002). In doing so, leaders demonstrate that the
selected course of action was the result of a rigorous analytical process, not personal preference.
Principal support. As highlighted earlier, leaders need to demonstrate that they are
willing to commit the necessary resources for change in order to motivate employees and
generate a sense of efficacy within the organization (Armenakis & Harris, 2002). Beyond
pledging resources, organizational members need to be assured that senior leaders are committed
to the change plan and its success. By being an integral part of the guiding coalitions for both
solutions, both the Chief Pharmacist and CHRO demonstrate their direct involvement and
personal investment in the implementation process and their support for the change effort.
Having representatives from all employee cadres (pharmacists, PTs, PAs) reflects a willingness
and desire for senior leadership to not just be inclusive in the decision-making process, but also a
commitment to ensuring that the support of all key stakeholders will be sought as it is integral to
the success of the change plan.
Valence. This component of the communication message answers the question “what’s in
it for me?” (Armenakis & Harris, 2002). By explaining how the proposed changes will benefit
stakeholders personally, leaders can rally support and win over skeptical employees who may be
resistant to change because they believe it threatens their self-interest (Armenakis & Bedeian,
1999). In the organization, this would involve senior leadership personalizing communication for
each group of employees (pharmacists, PTs, and PAs), and explaining how the expected
outcomes will benefit them. For example, by highlighting how the new workflow would allow
PTs to perform tasks autonomously, or by emphasizing to pharmacists how task delegation
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would allow them to dedicate more time to attend to patients’ needs, those employees are more
likely to support the change initiative. Framing the proposed changes in a personally meaningful
way has been shown to be effective at improving support and increasing employee commitment
to change (Kitchen & Daly, 2002; Klein, 1996).
Communication Strategy
While focusing on communication content is essential during organizational change, the
best-crafted messages can fall flat if they are not communicated effectively. Quite often,
organizational change initiatives falter because of the uncertainty they engender within
organizational members, generating anxiety which if not addressed can lead to resistance (Jick,
1993; Klein, 1996). As such, equally important to messaging content is the development of a
sound communication strategy. Klein (1996) proposed six principles that form the foundation of
a comprehensive communication strategy which will be employed in my OIP. Tables 10 and 11
below describe the application of Klein’s (1996) principles during the OIP’s implementation, and
a timeline of the communication plan, respectively.
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Table 10
OIP Communication Strategy Examples
Communication Principle (Klein, 1996)
Message and media redundancy

Application

•
•
•

Townhalls
Memo posting on staff bulleting board
Use of communication binder

Face-to-face communication

•
•
•

Townhalls
Use of daily team huddles
Biweekly staff meetings

Line of hierarchy as official communication
channel

•
•

Townhalls
Senior leadership attending staff
meetings
Memos & communication authored by
senior leadership

•

Direct supervisor as source of communication

•

Pharmacist (supervisor) as
communication vector (formal and
informal) during team shifts

Use of opinion leaders

•

Opinion leaders as representatives on
guiding coalitions

Use of personally relevant information (as
opposed to abstract, unfamiliar or general
information)

•

Employee-specific communication
(separate communication for
Pharmacists, PTs, PAs, in addition to
organization-wide communication)
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Table 11
OIP Communication Plan Timeline and Details
Source of
Timeline
Key Message
Communication
Senior Leadership
0 months
Share the vision for
change – why is
change needed?

Senior Leadership

Present organizational
analysis results;
highlight gaps.
Present change plan
(overview)
Regular progress
updates on both
solutions

Staff
representatives on
guiding coalition
(opinion leaders)

Share key milestones
(e.g., completion of
staff training; acquiring
new uniforms)

Guiding coalition

Senior Leadership
Guiding Coalition

1 to 4 months

5 months

Present findings of
workflow analysis and
new proposed
workflow to initiate
consultations
Pre-launch
announcement (Patient
Education Initiative)

Communication Strategy
1. Townhall led by Chief
Pharmacist & CHRO
2. Memos posted on staff
bulletin boards
announcing change
initiative
3. Memos included in
communication binder
1. Team huddles
2. Biweekly organizationwide meetings
3. Formal and informal
communication through
supervisors
4. Formal and informal
communication through
opinion leaders
(representatives on
guiding coalition) to
specific employee
groups
1. Townhall led by Chief
Pharmacist & CHRO
2. Memos posted on staff
bulletin boards
announcing change
initiative
3. Memos included in
communication binder
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Table 11 (continued).
6 months – Solution 1 Launched (Patient Education Initiative)
Guiding coalition 6-10 months
Regular progress
1. Team huddles
update on 2nd solution
2. Biweekly organizationwide meetings
Senior Leadership
3. Formal and informal
Provide updates on
communication through
initial results from first
Staff
supervisors
solution
representatives on
4. Formal and informal
implementation and
guiding coalition
communication through
any expected
(opinion leaders)
opinion leaders
modifications
(representatives on
guiding coalition) to
Share key milestones
specific employee
(e.g., completion of
groups
staff training; new
SOPs; installation of
new IT terminal;
physical layout
changes)

Senior Leadership

11 months

Present findings of
workflow analysis and
new proposed
workflow to initiate
consultations
Pre-launch
announcement
(Workflow redesign)

1. Townhall led by Chief
Pharmacist & CHRO
2. Memos posted on staff
Guiding Coalition
bulletin boards
announcing change
initiative
3. Memos included in
communication binder
12 months – Solution 2 Launched (New Pharmacy Workflow)
Senior Leadership 12 months &
Regular updates on
1. Team huddles
beyond
results of both
2. Monthly organizationsolutions
wide meetings
Supervisors
3. Formal and informal
communication through
supervisors

While Tables 10 and 11 provide a high-level framework of the details pertaining to the
implementation of the communications strategy, it is important to highlight the specifics of the
plan and the roles that different organizational members will play throughout the change
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initiative in order to provide a clearer understanding of the communications plan, which is
provided next.
Redundancy of message and medium. Message repetition and the use of multiple
media to deliver communication is linked to content retention (Dansereau & Markham, 1987;
Petty & Cacioppo, 1986). Within the organization, and at every stage of implementation,
communication will take place via multiple channels. Team huddles will be used to provide
regular weekly updates and communications related to the change initiative. The same messages
will also be posted in a written format on team bulletin boards and included in the
communication binders that pharmacy team members consult at the beginning of each shift.
Given that pharmacy work is divided in day and evening shifts, delivering communication via
these different media will ensure that information is properly promulgated throughout the
organization.
Face-to-face communication. Research has consistently shown that face-to-face
communication is more effective than any other method (Jiang et al., 2012). This is due in part to
the interactive nature of communication and the ability of the message recipient to ask questions
and seek clarifications as required (Gioia & Sims, 1986; Jiang et al., 2012). Prior to the
implementation of either solution, a townhall meeting will be held with all organizational
employees to announce the forthcoming changes and share the new vision for the organization.
During this meeting, senior leadership (Chief Pharmacist and CHRO) will present the results of
the organizational analysis and explain why change is urgently needed. The presentation will
also include an overview of the change plan, the timeline for implementation, and will set the
expectations for employees in terms of the training they will be required to complete. By
ensuring transparency and communicating openly, as well as providing clear directions, leaders
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will be embodying the core principles of Structured Relational Leadership, building trust and
paving a pathway towards change. Throughout the implementation of the change initiative,
representatives from the guiding teams will use the team huddles on a weekly basis as a means to
communicate with team members as well as solicit their input and feedback. Additionally, senior
leadership will conduct regular biweekly meetings with organizational members to provide
official status updates. One month prior to the launch of each solution, additional townhalls will
take place during which implementation specifics will be reinforced. These meetings will allow
organizational members to ask questions directly and will also be used to maintain momentum.
Line authority is an effective communications channel. Organizational members with
positional power (Bolman & Deal, 2013) are highly effective messengers. As indicated above, at
the beginning of the change initiative, senior leadership will hold a townhall meeting during
which they will present the vision for change, the implementation plan, and address any
questions that organizational members may have. Senior leadership should also be present for
meetings at key milestones during the implementation. In addition to meetings, official
memoranda and communications that will be posted on team bulletins and in the
communications binders should be endorsed or signed by senior leadership because
communication that comes directly from higher levels of the organizational hierarchy is often
viewed as more legitimate and taken more seriously (Miller & Barbour, 2015).
The supervisor is a key communicator. Linked to the previous principle, supervisors
are critical communicators during the implementation of change. In addition to holding
positional power and authority, supervisors are expected to be well-informed about changes
within the organization as they typically interact with senior leadership more frequently than
other members of the organization do. Given their daily and lengthy interactions with team
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members, supervisors are also best positioned to deliver and reinforce important messages.
Within the organization, pharmacists as the leaders during each shift act as supervisors, and there
is an expectation that they will play a key role in the communication strategy, both formally and
informally, ensuring that important messages make their way to support staff members.
The use of opinion leaders. Every organization has members who by virtue of their
collegial relationships and personality emerge as informal leaders within the organization
(Cialdini, Petty, & Cacioppo, 1981). These individuals have “a disproportionate impact on
others’ opinions and attitudes” (Klein, 1996, p. 36) and as such, can be important vectors for
communication during change initiatives. In the organization, every effort will be made to
include these opinion leaders as representatives on the guiding coalitions, which will further
enhance their ability to deliver messages effectively, while ensuring at the same time that they
are perceived as authoritative sources delivering accurate information. Leveraging opinion
leaders in the organization and including them on guiding coalitions will also have additional
benefits such as generating buy-in and gaining employee support (Kotter, 2012).
Personally relevant information is better retained. This communication principle is
related to the concept of valence that was discussed earlier. While organizational members will
be kept informed about the change initiative through the various strategies outlined above, it is
also important to ensure that employees don’t get inundated with a deluge of information that
may not be applicable to their roles. As such, throughout the change initiative, the guiding
coalition will also ensure that information that is specific to different groups of employees (e.g.,
PTs, PAs) is highlighted and communicated separately. This is where having representation from
all pharmacy team members on the guiding coalitions is highly beneficial, as each representative
can act as a conduit for delivering personally relevant information. For example, given that PTs’
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roles will change significantly in the new workflow, the PT representative on the guiding
coalition can ensure that all PTs are kept abreast of the impending modification to their roles
within pharmacy teams. Similarly, pharmacist representatives on the guiding coalitions can relay
critical information about the new expectations for pharmacists in terms of role delegation and
participation in clinic days. This type of personalized communication can also assuage employee
anxiety and ensure that the leadership team has clearly thought through the implications and
consequences of change for each employee group as opposed to applying a broad-stroke
approach to change that doesn’t take into account the differing needs and requirements of
employees.
Chapter Summary
Chapter three provided a detailed implementation plan for the two solutions proposed in
the OIP. The change effort that is described provides for a comprehensive approach that aims to
address the current gaps that exist in the organization. The ongoing improvement and
enhancement of the change plan is made possible by the iterative monitoring and evaluation
approach afforded by the PDSA cycle, as well as the careful and ongoing analysis of KPIs. The
proposed monitoring and evaluation approach will extend beyond the implementation of the
change plan as these metrics are integral to assessing the performance of the organization and
will continue to be collected and analyzed regularly. Finally, the chapter provided an inclusive
communication strategy and plan that focused on both the content of communication, making
sure it is tailored appropriately to the organization, as well as employed Klein’s (1996) key
principles that will ensure that communication efforts are in line with, and complement the
change plan. Through careful implementation, continuous improvement, and effective
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communication, it is expected that the organization can make significant strides in addressing the
problem of practice.
Next Steps and Future Considerations
This OIP’s problem of practice manifests itself through an interconnected and complex
set of symptoms at all levels of the organization and both internally and externally. At the macrolevel, the organization’s performance (e.g., safety incidents and dispensing errors) on its own is
worthy of study and analysis. Similarly, at the meso-level, pharmacy team interactions have
contributed to low employee engagement and morale, and the lack of proper integration of PTs
has led to serious concerns with pharmacist task delegation. At the individual level, in addition to
low morale, staff members face difficult choices: respond to patient demands for clinical advice
and risk committing serious ethical and safety breaches or decline and be the recipient of patient
complaints. While this operational landscape is certainly complex, it helps to be mindful that it is
primarily the result of external changes imposed on the organization by regulatory bodies and the
government. These concerns, as documented in chapter one, are not unique to my organization,
but are endemic to all community pharmacies in Ontario, in Canada, and other countries that face
similar changes (e.g., Bullock et al., 2016). From a practitioner perspective, this is actually a
promising sign that academics will continue to examine the impacts of regulatory changes on
pharmacy operations, and that the concerns raised in this OIP will continue to be the subject of
both debate and examination (Rosenthal et al., 2012). As such, one of the actions that I need to
maintain beyond this OIP is to monitor industry-wide trends and learn from the best practices of
organizations facing similar challenges.
It is also important to highlight the unique nature of community pharmacy practice. In
reviewing the literature in chapter one, and through the critical organizational analysis that was
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performed in chapter two, one theme that kept emerging relates to the challenges of operating in
both the public healthcare and private for-profit spheres. While the shift towards privatization is
a hallmark of neoliberalism, it is undeniable that pharmacists continue to struggle with their
professional identity and role perceptions, with many still viewing themselves as purveyors of
products to clients (Austin et al., 2006; Perepelkin & Dobson, 2009). Similarly, the public also
struggles with viewing themselves as patients as opposed to customers (Austin et al., 2006).
Viewed from a systemic lens, this a reflection of the larger paradigm shift that the industry is
undergoing in moving from a product to a patient-orientation. As with all paradigm shifts,
change requires time to take hold, and the full scope of the impacts of change cannot be fully
predicted.
While this OIP attempts to take a comprehensive approach to change, it is very likely that
future changes in legislation will happen. For example, there are currently some educational
programs that are geared towards training PAs in Canada, which could be an indication that their
role could become regulated in the future as well. Such a change would again alter the
operational dynamics between pharmacy team members and will require further analysis and
adaption on part of the organization. Scanning the environment regularly and interpreting
changes will therefore be critical to adapting my organization’s operational strategy beyond this
OIP (Beal, 2000; Thomas, Clark, & Gioia, 1993). It is for this same reason that participating in
the discourses that will likely take place between industry and government is an important future
step. As the healthcare system continues to face additional pressures, the role that community
pharmacies play in the delivery of services will likely continue to evolve, be it through additional
authorities that are given to pharmacists or enhanced collaboration with other healthcare
providers. By proactively engaging with key stakeholders, community pharmacies can help
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shape or inform the future direction that government decides to take. In doing so, community
pharmacies, through their representatives in the OCP and other professional bodies, can perhaps
mitigate serious concerns, such as the ones addressed in this OIP, as opposed to reacting to them
after the fact.
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